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ABSTRACT
MECHANOCHEMICAL CONTROL OF STEM CELL BIOLOGY
IN DEVELOPMENT AND DISEASE: EXPERIMENTAL AND
THEORETICAL MODELS
Polimyr Caesar Dave P. Dingal
Dennis E. Discher
Whether a stem cell remains or egresses away from its physiological niche is a function of
mechanical and soluble factors in a time-dependent manner, which implicates a ‘memory’
of prior mechanochemical conditioning. Virtually every organ in the body contains resident
stem or progenitor cells that contribute to organ homeostasis or repair. The wound healing
process in higher vertebrate animals is spatiotemporally complex and usually leads to scarring.
Limitations for the use of stem cells as regenerative therapy include the lack of expansion
capabilities in vitro as well as materials issues that complicate traditional biochemical protocols.
A minimal ‘scar in a dish’ model is developed to clarify the kinetics of tension-sensitive proteins
in mesenchymal stem cells (MSCs), which possess plasticity to mechanochemical changes
of the microenvironment that are typical of scars. The organization and expression of such
proteins implicates transcription factors that ultimately steer cell fate. In contrast to classic
mechano-transducers of matrix mechanics such as actin assembly-dependent serum response
factor (SRF) signaling, a novel mechano-repressive role of NKX2.5 is implicated in maintaining
intracellular tension in long-term stem cell cultures on stiff matrices via nucleo-cytoplasmic
shuttling – ultimately setting up a ’mechanical memory’. Core gene circuits with known roles
in stem cell mechanobiology are modeled based on the ’use it or lose it’ concept: tension
inhibits turnover of structural proteins such as extracellular collagens, cytoskeletal myosins and
nucleoskeletal lamins. This theoretical approach is tested in a variety of processes in vitro and
in vivo that involve forces including cardiac development, osteogenic commitment of MSCs, and
fibrosis therapy. With the sophistication of the science and technology of biomaterials relevant
iv
to stem cell biology and medicine, matrix mechanics can thus be rigorously combined with
biochemical instructions in order to maximize therapeutic utility of stem cells.
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Chapter 1
Matrix mechanics and soluble factors
combine to steer stem cell fate
This chapter appears in Nature Materials 13, 532-537 (2014) as a Commentary piece in a
focus issue on Cell Culture.
1
1.1 Introduction
The broad promise of stem cells for regenerative medicine is founded on decades of clinical
success already achieved with bone marrow transplantation of hematopoietic stem cells.
Current capabilities to induce pluripotency with any person’s terminally differentiated cells could
also revolutionize therapies for repairing or replacing many other damaged tissues. Yet direct
implantation of such cells causes teratomas — that is, tumors with regions of disorganized
fat, bone, epithelium or other tissues. Expansion of stem cells with at least partial lineage
specification in vitro through optimal control of the physicochemical milieu is therefore essential
to success in therapeutic applications. We highlight some key aspects of the interplay between
mechanical factors and soluble factors (Table 1.1) in both the physiological and in vitro milieu
of stem cells. We provide examples of how soluble-factor control of stem cell fate is modulated
by the physical microenvironment, and we discuss aspects of mechanobiological mechanisms
and potential research avenues requiring more attention and rigor.
1.2 Lessons from the niche
Stem and progenitor cells in adult organisms can maintain their multipotent state because of
‘signals’ that they receive in the protected, tissue-specific environment that is the stem cell niche
(Figure 1.1; Schofield, 1983). Signaling factors include soluble cytokines, cell–cell contacts,
and insoluble extracellular matrices with characteristic structure and physicochemical properties
(such as stiffness and softness) that define a cell orientation (O’Brien, 2013). Apical–basal
polarity is common, and seems to poise a stem cell for asymmetric division — that is, the
generation of one differentiated cell with the stem cell remaining in its niche. Otherwise, niches
vary with tissue type, as discussed below for soluble and insoluble microenvironments of four
distinct adult stem cells.
2
1.2.1 Hematopoietic stem cell niche
Haematopoietic stem cells (HSCs) remain the best described somatic stem cells, but how they
are maintained in their adult niche(s) within the bone marrow or otherwise how they egress
into the circulation remains an active area of research. Embryonic niches for these cells are
distinct and precede establishment of bone. One niche for adult HSCs comprises nestin-positive
mesenchymal stem cells (MSCs) and endothelial cells that are spatially associated near the
perivascular microenvironment (Mendez-Ferrer et al., 2010); yet proximity to trabecular bone
and bone cells also seems important in another HSC niche (Morrison and Scadden, 2014).
All of these bone marrow cells, as well as factors present near the bone surface, could help
to promote HSC quiescence, with key niche cytokines including stem cell factor (SCF) and
stromal cell-derived factor 1 (SDF-1) (Morrison and Scadden, 2014; Peled et al., 2000). MSCs
and other stromal cells play an important role in the homing of HSCs to the niche – especially
after myeloablative therapy, that is, the depletion of bone marrow cells by means of chemo- or
radiotherapy before transplantation — perhaps chemoctactically driven via SDF-1. For example,
SDF-1-induced expression of matrix metalloproteinase-9 (MMP9) in bone marrow cells can
enzymatically release matrix-bound SCF, which can then permit the recruitment of repopulating
cells and also promote the proliferation of normally quiescent HSCs (Heissig et al., 2002).
The ability of stem cells to divide asymmetrically is a characteristic niche process that
maintains stemness under homeostatic or inflammatory conditions to replenish blood cells. The
mobilization of HSCs through the induction of granulocyte colony-stimulating factor (G-CSF;
another soluble niche factor) was first demonstrated in the early 1990s, yet little is known about
HSC trafficking within the bone marrow before egress into the bloodstream, particularly towards
lineage specification and possibly to other sub-niches. Physiologically, HSC mobilization follows
circadian oscillations (Mendez-Ferrer et al., 2008), yet relations to local pressure, flow and other
circulating factors remain obscure; oxygen certainly regulates the behavior of stem cells (Keith
and Simon, 2007).
The expansion of haematopoietic stem and progenitor cells is also biophysically regulated
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(as suggested by Lichtman and Kearney in the 1970s, who anticipated key roles for “contracting-
relaxing [. . . ] macromolecules in motile cells”). In blood cells, a major impediment to migration is
the nucleus, and regulation of its deformability probably modulates hematopoietic cell trafficking
and lineage. Indeed, nucleoskeletal-lamin (Shin et al., 2013) and cytoskeletal-myosin (Shin
et al., 2014) isoforms differentially regulate egress and lineage maturation of HSCs. In
particular, myosin IIB promotes cell polarization to generate more blood progenitors, whereas
myosin IIA supports a more symmetric division. Interestingly, reversible inhibition of myosin
II, and soft matrices that mimic the compliance of marrow (and also tend to suppress myosin
II), both favor long-term HSC reconstitution (Shin et al., 2014). Tropoelastin, which is also
highly compliant, has an additive effect with serum-free cytokine cocktails (of IL-3, IL-6 and
SCF) in supporting repopulating HSCs in vitro; yet stiffening of tropoelastin by glutaraldehyde
crosslinking abrogated the effect (Holst et al., 2010). The myosin-II inhibition strategy also
enriches for megakaryocytes of high ploidy (Shin et al., 2013) and pro-platelet generation (Shin
et al., 2011), and thus seems to be key in directing at least some lineage programs. On the
whole, the tight regulation of HSC niche components plays a crucial role in stem cell quiescence,
with feedback and feed-forward mechanisms between cells and soluble and insoluble factors.
1.2.2 Muscle stem cell niche
Host muscle fibre, interstitial cells, basal lamina and a nearby blood circulation seem to be
the main components of the niche for muscle stem cells (also known as satellite cells) (Kuang
et al., 2007). In satellite-cell homing during development, canonical Notch signals that occur
asymmetrically at cell–cell contacts — which control multiple cell differentiation processes —
stimulate emerging satellite cells to assemble their own basal-lamina matrix (Brohl et al., 2012).
Integrin binding to laminin in this extracellular matrix localizes to the basal side of satellite
cells, whereas M-cadherin localizes to the apical side for attachment to the host muscle fibre
(Kuang et al., 2007). It has been hypothesized that the basal adhesion regulates stem cell
quiescence through inhibition of caveolin-mediated endocytosis of soluble factors, and that the
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polarized distribution of adhesion molecules determines the asymmetric fate of daughter cells
after division (Kuang and Rudnicki, 2008). The one daughter cell that maintains contact with
the basal lamina maintains a self-renewal capacity, whereas the other is pushed into the host
myofibre and presumably differentiates (Kuang and Rudnicki, 2008).
On injury, activated satellite cells remodel their niche through autologous expression
of fibronectin, feeding back to Wnt7a signaling (a pathway known to be implicated in
developmental processes), which in turn induces symmetric expansion of satellite cells
(Bentzinger et al., 2013). Collagen VI is also produced by satellite cells, with collagen-VI
knockout mice showing impaired muscle regeneration with decreased muscle stiffness (from
12 kPa to 7 kPa) (Urciuolo et al., 2013). Consistent with this, in vitro satellite cell maintenance
and subsequent muscle engraftment is maximal when culturing on substrates that match normal
muscle tissue stiffness (∼12 kPa; Engler et al., 2004a; Gilbert et al., 2010). Nonetheless, such
cell cultures exhibited lower regenerative capacity in vivo than cells freshly isolated from muscle,
which suggests that some combination of biophysical and biochemical elements of the muscle
stem cell niche have yet to be identified for optimal cell culture.
1.2.3 Neurogenic niche
The relatively recent discovery of adult neural stem cells (NSCs) and of the signals regulating
adult neurogenesis illustrates differences with the early development of the brain. In embryonic
neurogenesis, all cells derive from neuroepithelial cells that divide symmetrically at first
(Chenn and McConnell, 1995). In adults, however, the NSC niche is restricted to the
ventricular–subventricular zone of the lateral ventricle and to the subgranular zone at the
interface of the hilus and dentate gyrus in the hippocampus (Alvarez-Buylla and Lim, 2004).
As with satellite cells, canonical Notch signaling is highly active and regulates maintenance of
both developing and adult brains (Imayoshi et al., 2010). More importantly, the neocortical
niche architecture is maintained by integrin-based adhesion of NSCs to laminin along the
apical (ventricular) surface (Loulier et al., 2009). Similar to the HSC niche, SDF-1 secretion by
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ependymal cells at the apical surface maintains NSC quiescence, whereas SDF-1 secreted by
endothelial cells of the vascular basal region results in chemotaxis by both activated NSCs and
progenitors in an integrin-α6β1-dependent manner. Transition from progenitors to neuroblasts
is marked by β1-integrin downregulation, enabling egress from the niche (Kokovay et al., 2010).
The process seems to prompt asymmetric cell division, with the NSC staying in its niche and
the resulting daughter cell moving into more differentiated basal regions of the niche. The
highly polarized NSC niche thus allows for compartmentalization of multiple signals derived
from cell–cell and/or cell–matrix adhesions as well as of soluble factor gradients that combine
to maintain NSC polarity and stemness (Fuentealba et al., 2012).
1.2.4 Multifunctional mesenchymal stem cells
MSCs can take on lineage characteristics of various soft- and hard-tissue cell types (such as
neurons, adipocytes, chondrocytes, osteoblasts, skeletal myoblasts and smooth muscle cells),
and thus they are an attractive choice for autologous transplantation (Pittenger et al., 1999).
Among the various types of adult stem cell, MSCs (from the bone marrow or other sources)
that have been isolated through strong adhesion to plastic seem to have the broadest lineage
potential (Colter et al., 2000); also, they expand for prolonged periods on tissue-culture plastic
while maintaining some degree of multipotency (Abdallah and Kassem, 2009). Other materials
might do better, but traditional plastic has allowed MSCs to be used in additional in vitro systems
to identify soluble and insoluble cues that induce differentiation.
By mimicking the characteristic stiffnesses of different tissues (for instance, brain tissue is
always soft; bone tissue is rigid) with inert hydrogels functionalized with collagen I, it was shown
that matrix elasticity can direct MSC lineage specification from soft brain to stiff bone and that
myosin II has a key role in pulling on and feeling matrix elasticity (Engler et al., 2006). Microarray
analyses also indicated significant increases in some key factors of the transforming growth
factor beta (TGF-β) superfamily such as bone morphogenetic proteins (BMP) and myostatin
(also known as growth differentiation factor 8; GDF8) (Engler et al., 2006). MSCs respond
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to such TGF-β-family growth factors (Wang et al., 2004), as expected of mesenchymal cells,
which means that growth factors could have key autocrine/paracrine signaling roles and that
these are triggered by matrix elasticity. For example, MSC injection into scars (which tend to
be stiff) such as those resulting from myocardial infarcts has sometimes led to bone formation
in the scar; in this case, matrix stiffness may trigger an increase in BMP, which is likely to be
the proximal cause for osteogenesis (Breitbach et al., 2007). Such potent growth factors may
thus contribute to lineage-inducing signals, even if differences in their expression or activation
imparted by physical features of the microenvironment such as matrix elasticity are small (say,
at the picomolar level). With respect to three-dimensional culture models (Khetan et al., 2013;
Huebsch et al., 2010), many questions arise that should be rigorously addressed, including how
cell-secreted growth factors and extracellular matrix binds or not to the surrounding scaffold or
gel, whether the various soluble serum or induction factors added to cultures permeate the gel
(including oxygen gradients studied decades ago in three-dimensional cultures; Colton, 1995),
and also how far the cells reside above a rigid substrate that they might feel. Understanding
the various triggering mechanisms in two dimensions as well as three dimensions is likely to be
important in physiological conditions, yet it is also possible that adding a growth factor such as
BMP to cultures of cells in microenvironments with different stiffnesses will yield different cell
phenotypes.
1.3 Soluble factors with contrasting function
The main TGF-β reservoir in serum resides in platelets, and TGF-β is secreted on platelet
activation in a matrix-binding, latent complex form (Ahamed et al., 2008), from which it can be
released by high fluid shear. Evidence for TGF-β release resulting from cell tension was first
obtained with contractile myofibroblasts, the characteristic cell type in stiff, fibrotic tissue (Wipff
et al., 2007). Following release, TGF-β1 binds membrane receptors that activate ubiquitous
transcription factors (such as SMADs), which enter the nucleus to promote matrix synthesis
and the expression of contractility proteins such as α-smooth muscle actin during fibrotic
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wound healing by myofibroblasts. Although intracellular processes are probably modulated
by the microenvironment, an interplay with TGF-β1 release mechanisms seems likely to occur
in vivo. For example, in patients with coronary artery disease an increase in active, but not
total, TGF-β1 in plasma correlates with the number of constricted vessels in the patient (Wang
et al., 1997); hence, constricted or stenotic vessels have higher shear stresses and thus higher
concentrations of active TGF-β (the release kinetics of active TGF-β with shear stress and time
characterizes the forced unfolding of a protein, and the unfolding seems to be roughly linear
with shear stress and lacks a threshold; Tenney and Discher, 2009). Given its subnanomolar
concentrations in serum, however, TGF-β activation at low stress would take a long time. In
the marrow niche where flow is minimal, glial cells of the autonomic nervous system (known as
non-myelinating Schwann cells) produce TGF-β and activate it via integrin β8 to help maintain
HSC dormancy (Yamazaki et al., 2011).
Unlike most protein-based growth factors, which cannot cross cell membranes, retinoic
acid (RA) is a much smaller molecule that readily permeates cell membranes and regulates
ubiquitous transcription factors that shuttle between the cytoplasm and the nucleus (oxygen is
another example). In adults, RA is converted in the liver from ingested vitamin A and circulates
in serum (∼10 nM). RA signaling seems somehow primed in adult HSCs in part by the niche
stroma (Ghiaur et al., 2013), and it is essential for the generation of early embryonic HSCs from
the haemogenic endothelium (Chanda et al., 2013). In HSCs, RA receptor-γ (RARγ) regulates
the balance of HSC self-renewal and differentiation (Purton et al., 2006), with RARα promoting
granulocyte commitment. Indeed, RA suppresses erythropoiesis (Labbaye et al., 1994) and
enhances neutrophil differentiation (Shin et al., 2013). Although RARs regulate expression of
many genes (up or down), its downregulation of at least the nuclear structure protein lamin A
proved revealing: neutrophils have soft, floppy nuclei with low levels of lamin A, which allow
these cells to easily crawl through endothelial pores from marrow into blood, and also to enter
distal tissues. In contrast, erythroblasts normally maintain high levels of lamin A in their stiff,
condensed nuclei; these nuclei are easily ejected in final differentiation and retained in the
marrow, with the enucleated cell entering circulation as a red blood cell.
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Lamin A is an intermediate filament protein related to keratins in nails, hair, beaks and
horns. In addition to controlling nuclear deformability, lamin A has a role in maintaining DNA
stability, and is also mechanoresponsive, as we have recently shown (Swift et al., 2013b). Its
levels scale with the stiffness of primary tissue (0.1–40 kPa), and in cultured MSCs the levels
increase with the stiffness of hydrogel substrates. Lamin-A levels in MSCs on stiff matrix are
also modulated by RA levels, with more RARγ entering the nucleus in cells on stiff matrices
than in cells on soft substrates (Figure 1.2). Brain is low in RARγ, but has other RARs (Swift
et al., 2013b); in serum-free NSC cultures adhering to a narrow range of flexible substrates
(10–1,000 Pa) and even under strong pro-neuronal conditions (1 µM RA), commitment to
specific lineages is stiffness-dependent (Saha et al., 2008). Similar observations were made
with NSCs encapsulated within alginate hydrogels of stiffness matching that of brain tissue
(Banerjee et al., 2009).
The regulation of the nuclear entry of transcription factors by matrix elasticity might actually
be general. Other transcription factors whose nuclear entry is also known to be regulated by
matrix stiffness include the YAP/TAZ co-activators (Swift et al., 2013b; Dupont et al., 2011;
Yang et al., 2014) and key lineage-specific factors for muscle (MyoD) and bone (core-binding
factor alpha 1; CBFA1) (Engler et al., 2006). Some of these participate in signaling pathways
(such as the Hippo pathway for YAP/TAZ) that are also regulated by soluble factors (such as
lipopolysaccharide). Nucleo-cytoplasmic shuttling of glucocorticoid receptors for natural and
synthetic glucocorticoids such as dexamethasone need to be studied thoroughly as a function
of matrix properties because glucocorticoids are frequently used in differentiation cocktails
(Grigoriadis et al., 1988). Target genes in these pathways that are differentially expressed as a
function of matrix properties and soluble-factor levels provide key evidence of functional nuclear
entry or exit of a transcription factor. Epigenetic memory is also key to stem cell responses. For
example, if MSCs are grown for one to three weeks on soft matrices (1 kPa) that tend to induce
expression of a neurogenic marker, and then an osteoinduction cocktail is added, one finds that
the neurogenic expression is largely reversed in the one-week cultures but not in the three-week
cultures (Engler et al., 2006) (Figure 1.3). A lineage choice can be likened to a fork in a road
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going downhill that does not require much steering to choose, but the further down a chosen
fork, the more difficult it is to reverse the fate/choice. Recent studies of the nuclear localization
of YAP/TAZ in MSCs cultured on stiffness-switchable hydrogels confirm the idea of a matrix
memory (Yang et al., 2014). How such transcriptional regulators are preferentially sequestered
in the cytoplasm rather than the nucleus is generally unknown, but immunoprecipitation of
the factors followed by mass spectrometry can help identify validatable binding partners in
the cytoplasm and nucleus, as recently shown for RARγ (Swift et al., 2013b). Far better
characterized in this respect is the actin-regulated serum response factor pathway (Miralles
et al., 2003; Swift et al., 2013b), which couples directly to the mechanosensitive assembly of
the actin–myosin cytoskeleton.
1.4 Harnessing pluripotency
Responses of embryonic stem cells (ESCs) to mechanical stress and stiffness are beginning
to be clarified. The softness of embryos (∼400 Pa) results from a relative lack of extracellular
matrix even when compared with the earliest beating heart (Majkut et al., 2013). The softness of
ESCs dictates the threshold for stress-driven, myosin-II dependent spreading and differentiation
of mouse ESCs, but not of ESC-differentiated cells that are ten times stiffer (Chowdhury et al.,
2010b). Similar to the matrix-modulated differentiation of MSCs, soft substrates that match
the intrinsic softness of ESCs (600 Pa) suppress cell–matrix tractions and maintain the ESCs’
self-renewal potential (Chowdhury et al., 2010a).
Inhibition of Rho-associated protein kinase (ROCK), an effector of myosin contractility,
dramatically enhances survival of dissociated human ESCs (hESCs), with no effects on ESC
differentiation (Watanabe et al., 2007). Decreased cell–cell contact has also been shown to
reduce survival of dissociated hESCs (Chen et al., 2010) because of irreparably disrupted E-
cadherin signaling (Xu et al., 2010). Enhancing cell attachment immediately after dissociation
greatly improves survival, and is suggested to be partly a consequence of the synergy between
integrin signaling and growth-factor signaling (Xu et al., 2010). Mechanical straining of hESCs
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on stiff substrates synergizes with soluble factors to inhibit the differentiation of pluripotent cells
and to enhance their self-renewal (Saha et al., 2006; the physiological relevance of the strain
needed, about 10%, is however unclear). Soft substrates might nonetheless be combined
with externally imposed strains and suitable biochemical signals to maximize pluripotent cell
numbers. For therapeutic applications, ESC expansion should be done without the usual
underlying feeder cells (commonly, fibroblasts), which introduce biological variation and sources
of immune rejection. The standard for ESC culture involves mouse tumor-derived Matrigel (∼1
kPa) to increase cell adhesion, and high concentrations of TGF-β and basic fibroblast growth
factor to antagonize differentiation (Rao and Zandstra, 2005). Current research is however
focused on synthetic surface-engineered surfaces for xeno-free human pluripotent stem cell
(hPSC) culture under chemically defined conditions, which should allow for scalability without
the risks of cellular or pathogenic contamination. Examples include ultraviolet-treated spatial
patterns (Saha et al., 2011) and peptide-decorated acrylate surfaces (Melkoumian et al., 2010).
A high-throughput study on biomaterials development also found acrylate surfaces to be optimal
for clonal growth of hPSCs (Mei et al., 2010). Materials that can accelerate hPSC expansion
(Celiz et al., 2014) are needed for regenerative-medicine applications.
The discovery and development of human induced pluripotent stem cells (hiPSCs;
Takahashi et al., 2007) was immediately followed by a flurry of research into therapeutic
applications, in particular neurological diseases. A recent kinome-wide study of iPSCs
highlighted the role of actomyosin polymerization through kinase-mediated phosphorylation
of cofilin (a protein that disassembles actin filaments) as one major barrier to efficient
reprogramming to iPSCs (Sakurai et al., 2014). It is then not surprising that NSC profiles are
more similar to ESCs than to NSC-derived differentiated cells (Ramalho-Santos et al., 2002),
not only because of default neurulation tendencies of ESCs (brain development is very early;
Tropepe et al., 2001) but also perhaps because of the similarity in softness of embryos and
the neural microenvironment relative to other tissues such as embryonic heart (Majkut et al.,
2013). Indeed, hPSCs integrate readily into the motor cortex and undergo cortical neurogenesis
without added morphogens (Espuny-Camacho et al., 2013). However, direct implantation of
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hESCs into various other tissue sites produces heterogeneous teratomas (Prokhorova et al.,
2009). Reprogramming in vivo also produces teratomas as well as iPSCs with totipotency
features that are not possible in standard in vitro reprogramming (Abad et al., 2013).
Since the first bone marrow reconstitution after myeloablative therapy decades ago,
functional tissue regeneration with other types of stem cell has been the vision of many.
Enabling technologies include cell phenotyping by flow cytometry with antibodies against
lineage-distinctive arrays of cell-surface receptors. However, HSC transplantation is successful
because of the intrinsic ability of HSCs to ‘home’ to the bone marrow and find their niche(s). The
promise of iPSC technology to produce all diverse cell types in a given solid tissue is tempered
by a poor understanding of microenvironmental factors that direct stem cell fate, as well as of
lineage phenotyping and uncertainty over how to control the mobility and engraftment of cells
(Yu et al., 2013). Commitment to a lineage in vitro before implantation seems essential and
necessarily brings culture materials into a protocol, but also complicates the various efforts.
Yamanaka and Gurdon’s 2012 Nobel prize in Physiology or Medicine has largely fixed
the trajectory of most of the currently envisaged stem cell-based therapies into using iPSCs
generated from suitably matched donors. Yet high-efficiency reprogramming and tissue
specification remains a major challenge, as does delivery and survival in vivo. Therapies with
any type of stem cell should eventually be compared to normal tissue, but technologies to
ascertain cell integration and contributions to diseased tissue require more rigor than is typical
with decades-old histological methods. For example, putting human cells in immunodeficient
mice is the current standard in the HSC field; however, for similar studies with solid tissues,
human versus mouse proteomics (Swift et al., 2013b) and RNA-sequencing can be used to
reveal the contributions of stem-cell-derived xenografts to obtain systems-level views of the
myriad of factors that come into play for fully functional transplants. With the wide range of
material and analytical technologies emerging to help the translation from in vitro to in vivo,
challenges in concepts and applications seem increasingly addressable with suitable rigor and
reproducibility for translation into humans.
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Table 1.1. Glossary of factors and proteins most relevant to stem cell mechanobiology
Growth Factors
SCF, stem cell factor
transmembrane or soluble cytokine produced by fibroblasts and
endothelial cells that binds to the c-Kit receptor (CD117) to help
HSC in homing to and maintenance of the niche
SDF-1, stromal cell-derived
factor
soluble chemotactic cytokine for HSC homing to the marrow
G-CSF, granulocyte
colony-stimulating factor
soluble glycoprotein that promotes stem cell granulopoiesis
TGF-β/BMP, Transforming
growth factor-β / Bone
morphogenetic protein
soluble or matrix-bound growth factors that promote cell growth,
differentiation and matrix synthesis
bFGF, basic Fibroblast
growth factor
soluble or matrix-bound factor, used as supplement in culture
medium for ESC maintenance
RA, Retinoic acid
membrane-permeable vitamin-A metabolite with roles in neutrophil
differentiation; implicated in nucleus deformability
IL, Interleukin
membrane-bound or matrix-bound cytokines produced mostly by
the immune system to regulate production, differentiation and
function of blood cells
Transcription factors
RAR, Retinoic acid receptor
on binding of RA, RAR heterodimerizes with retinoid X receptor
(RXR) to bind to a retinoic acid response element (RARE) on a
target gene, such as LMNA
SRF, Serum response factor
binds to serum response element (SRE) of genes responsible for
controlling cytoskeletal structures involved in, for example, cell
spreading, adhesion and contractility
SMAD, Sma and Mad
related family
TGF-β/BMP family of ligands bind to their receptors, which in
turn activate SMAD signaling and bind to SMAD-binding elements
(SBE) in target genes, such as COL1A1
YAP/TAZ, Yes-associated
protein / Transcriptional
co-activator of PDZ-binding
motif
involved in the Hippo signaling pathway, responsible for cell-size
control; recently shown to be crucial in transducing mechanical
signals from ECM to nucleus, in an actomyosin and Rho-
dependent manner and independent of the Hippo pathway
Matrix, adhesion, and cyto-/nucleoskeletal proteins
Collagen
the most abundant protein in animals; it confers the majority of
tissue structure and stiffness
Fibronectin
usually found as a provisional matrix component in embryonic
development and wound healing
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Table 1.1. (continued)
Matrix, adhesion, and cyto-/nucleoskeletal proteins
Laminin
basement membrane protein that helps maintain the apical–basal
polarity of stem cell niches
Integrin
transmembrane heterodimeric protein that binds to the extracellular
matrix
Cadherin transmembrane protein that mediates cell–cell adhesion
Actin
highly abundant protein that forms microfilaments (a major
cytoskeletal structure); essential for migration, contractility, and cell
division
Myosin
provides the basis for cell contraction by binding to actin filaments
in an ATP-dependent manner
Lamin
a class of intermediate filaments (a major cytoskeletal structure)
found in the nuclear envelope; provides structural function and
transcriptional regulation
Nestin
a class of intermediate filaments expressed mostly in nerve
cells; also found in mesenchymal stem cells and newly formed
endothelial cells
Examples of synergy between soluble and insoluble factors
Tropoelastin & serum-free
cytokine cocktail (IL-3, IL-6
and SCF)
HSCs repopulate on soft tropoelastin but not on stiff, crosslinked
tropoelastin even with the presence of cocktail
Matrix-bound SCF and
SDF-1 induced MMP9
expression
MMP9 releases SCF and permit HSC repopulation and
proliferation of quiescent HSCs
Matrix-bound TGF-β
activated with shear flow or cell-derived force; implicated in
progressive fibrosis
Mechanosensitive lamin A
and retinoic acid signaling
lamin A increases with tissue stiffness, and primes RARγ to enter
nucleus and to promote RA signaling
Soft substrate and retinoic
acid in NSC cultures
NSCs commit to neurons only on very soft substrates even under
strong pro-neuronal conditions
Matrigel, TGF-β and bFGF maintains ESC pluripotent state
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Figure 1.1. Lessons from the niche. A, The insoluble and soluble milieus in a stem cell niche
specify apical–basal polarity and help maintain stemness. Signaling factors include cell–cell
(segmented rods) and cell–matrix contacts (wiggly lines represent the matrix; rod-shaped
dimers at the cell boundary represent membrane-bound integrins), membrane-permeable
molecules (green hexagons; green, purple and red circles) and matrix-bound factors (blue
ovals). B, Asymmetric cell division results in differentiating daughter cells. C, Migration out of
the niche is affected by both extrinsic barriers (such as other cells or the matrix in, for example,
endothelial pores; green and brown semi-circular structures, right) and intrinsic factors, such
as the nuclear lamina (orange line encircling cell nuclei). For example, neutrophils have very
low lamin-A (that is, softer nuclei) and can thus easily enter the circulatory system (red region,
lower right).
15
LMNARARE
SBE
STIFF MATRIX
PP
LMNARARE
SOFT MATRIX
COL1A1SBE
S O
FT
 NUC LEU
S
COL1A1
Retinoic Acid
TGFβ
Integrin
TGFβ Receptors
Focal adhesion
G-Actin
MAL/SRF
Myosin
Lamin-A
Collagen
RARγ
SMAD2/3
SMAD4
Figure 1.2. Matrix and soluble factors converge to control lamin-A levels. Left, in soft
tissues, collagen is low, cells do not contract, and the nucleus is not tensed. Lamin A is
turned over and RARγ is mostly cytoplasmic, with no appreciable soluble agonist effects.
Right, as collagen content increases (as in stiffer tissues or in fibrosis), a cell forms stable
focal adhesions, a stable actomyosin cytoskeleton, and a tension-stabilized nucleus. Tension-
mediated activation of matrix-bound TGF-β leads to collagen and lamin-A production, and to
RARγ nuclear localization. This primes the stem cell to respond to RA, which in turn represses
lamin-A transcription.
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Figure 1.3. Stem cells have a time-dependent ‘memory’ of prior conditioning. MSCs
grown on soft, neurogenic matrix in standard media are induced towards neurogenic lineage
(green), yet can be challenged by osteoinduction media that redirects them towards an
osteogenic lineage (red) during the first 1-2 weeks after initial induction by the matrix. Figure
adapted from Engler et al. (2006).
17
Chapter 2
A minimal ‘scar in a dish’ model
reveals mechano-temporal effects of
matrix stiffness on stem cell fate
Portions of this work are under peer-review in Nature Materials.
3D decellularized heart models were performed by Dr. Matthew Raab.
Proteomics analyses of mouse tissue were performed by Dr. Joe Swift.
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Abstract
Scarring in higher animals compromises tissue function and is highly complex, which motivates
the development of culture systems that clarify cellular mechanisms and that might also
help identify therapeutics. Co-polymerization of collagen-I with polyacrylamide produced
scar-like, crosslinked fiber bundles that segregated heterogenously atop the hydrogel and
directed the fate of multiple cell types towards scar-like phenotypes. As with scars, the gels
stain non-uniformly with Sirius Red dye and are regionally stiff. Cardiomyocytes derived
from pluripotent stem cells do not beat on scar-like gels, consistent with defective beating
of scarred hearts. Mesenchymal stem cells (MSCs), which traffic to injured sites, ‘durotax’
towards mimetic scars, undergo osteogenesis consistent with ossification of some scars,
and upregulate tension-sensitive proteins. Within hours, myosin IIB polarized rearward in
stress fibers and nucleoskeletal lamin-A levels increased as cells and nuclei spread, but 1-
2 days were required to upregulate the ‘scar marker’ α-smooth muscle actin. Agonists to
one pathway involving retinoic acid receptors inhibited scar-induced differentiation, with similar
effects evident in the mechano-regulated fates of progenitor-derived macrophages that remodel
scars. Mechanobiological gene circuits are modeled mathematically, illustrating how key
features of scars in soft tissues can be usefully studied in culture.
2.1 Introduction
Scarring is an unavoidable consequence in mature higher vertebrates of survivable injuries that
range from external trauma to acute events such as myocardial infarction and various chronic
diseases (Gurtner et al., 2008). Fibrotic, heterogeneous matrix is the defining feature of a scar
and consists predominantly of excessive, crosslinked collagen-I bundles, which displace cells
and less oriented matrix and thereby limit tissue function (Martin, 1997). Across striated muscle
diseases, for example, collagen-I expression increases up to ten-fold or more relative to normal
levels (Bakay et al., 2002), and scarred tissue also tends to be stiffer (Engler et al., 2004b;
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Tomita et al., 1999). An increase in tissue stiffness is predictable because collagen-I, being the
most abundant protein in animals, makes key structural networks (Munster et al., 2013), and
this is seen in most fibrotic tissues (Figure 2.1). However, many additional changes in scarred
tissue can be detected, including proportional increases in the nuclear structure protein lamin A
versus collagen-I (Figure 2.1B,C). For normal tissues, we have shown recently that lamin-A
levels scale with collagen-I and are mechanosensitive in vitro (Swift et al., 2013b), but given the
complexity of scars in vivo in terms of diverse cell types, matrix, and soluble factors, it is unclear
whether lamin A and the transcription factors it regulates are responsive in any given cell type
to a heterogeneous scarring microenvironment.
Cell therapies for many types of scarred tissues are being pursued with a wide range of
cell types, and the list will no doubt grow with the emergence of various stem cells, including
pluripotent cells (Boiani and Scholer, 2005) and adult mesenchymal stem cells (MSCs; Pittenger
et al., 1999). Whether stem cell-derived lineages are plastic and change phenotype when
engrafted into scars is a critical question for cell therapy, particularly for MSCs that are
multipotent as well as immunomodulatory. A mechanochemical gradient is also likely wherever
normal tissue transitions to scar (Tomita et al., 1999; Pfeffer and Braunwald, 1990), and an
impact on cell trafficking into scars will likely affect cell and tissue fate (Orlic et al., 2001).
Matrix ligand type and density provide signals complementary to matrix mechanics (Engler
et al., 2004b) in influencing cell behavior such as MSC differentiation (Engler et al., 2006;
Huebsch et al., 2010; Trappmann et al., 2012; Khetan et al., 2013), but recent studies of matrix
tethering (Trappmann et al., 2012), topography (McNamara et al., 2010), crosslinking, and in
three-dimensional (3D) models (Huebsch et al., 2010; Khetan et al., 2013; Liu et al., 2012; Ulrich
et al., 2009; Levental et al., 2009) have stirred debate on the influence of matrix mechanical
properties in cell-fate decisions. Stiffness of scars (e.g. in skin) measured in the macroscopic
(in MPa; Corr et al., 2009) versus microscopic (in kPa; Achterberg et al., 2014) scales yield
vastly different numbers. A clear relationship to specific tissue parameters is an important goal
of new cell-culture material systems (MacQueen et al., 2013). Here we focused on microscale
elasticity of tissues (and gels) since cells sense on the same scale. With heterogeneous scar-
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like culture platforms here, we make a range of comparisons to scarred tissue (Figure 2.1) and
ultimately show that the effective stiffness of a scar is key to cell fate signals.
2.2 Results and Discussion
2.2.1 Hydrogels with scar-like collagen fiber heterogeneity and
regional rigidity
Starting with an allylsilane-modified ‘bottom’ coverslip that anchors polyacrylamide (PA) chains,
we discovered that mixing collagen-I (Col1) heterotrimers into the PA precursor solution
promotes Col1 fibril formation with segregation to within ∼10 microns of the gel interface
during free-radical polymerization (Figure 2.2A,B). Importantly, the embedded Col1 gels stain
positively but heterogeneously for the histochemical dye, Sirius Red (Figure 2.2C), which is
widely used to assess tissue fibrosis (Turgeman et al., 2008; Mann et al., 2011; Georges et al.,
2007). Sirius Red staining was not observed, in contrast, with Col1 coated (CC) conventionally
on the PA gel surface (Figure 2.2C) via a standard sulfo-SANPAH-mediated covalent reaction
widely used for culture substrates (Dembo and Wang, 1999). The embedded Col1 was varied to
approximate the Sirius Red area fraction visible in typical sections of scarred tissue (20–30%,
Figure 2.1). Surprisingly, initial studies of cells cultured on the embedded Col1 gels showed
that ligand density on fiber bundles was below the threshold needed for cell adhesion, and so
the conventional ‘CC’ modification was used to obtain cell-adhesive scar-like0.3kPa gels with
bundles of collagen that were stable for at least 7 days in cell culture (Figure 2.3). This minimal
matrix model of a scar provides separate control over matrix elasticity and ligand density,
which is not possible in pure collagen gels where ligand density changes with collagen density.
Furthermore, collagen gels exhibit non-linear elasticity (Storm et al., 2005) and stiffen under
strain induced by incorporating cells (Vader et al., 2009), which complicate matrix-mechanical
effects on cell responses.
Consistent with interfacial formation of fibril bundles, the embedding of Col1 (0.04%
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w/v) showed no significant effect on the gel’s bulk modulus (E ≈ 2.9G′ = 0.3 kPa; 3%
acrylamide, 0.07% bis-acrylamide w/v), and for all gels, the elastic modulus dominated the
viscous modulus (Figure 2.4A). Unlike PA gels, collagen fiber networks typically show non-
linear strain stiffening independent of crosslinking (Munster et al., 2013), which becomes
insignificant in the embedded system here that is predominantly elastomeric. However, because
a surface-adherent cell feels only a few microns deep into a gel (Buxboim et al., 2010), the
surface microelasticity Esurf seemed critical to measure. We started with conventional micro-
indentation by atomic force microscopy (AFM; Engler et al., 2007), with results for pristine or CC
gels identical to bulk rheology (Figure 2.4Bi). Microelasticity maps of scar-like0.3kPa gel surfaces
proved to be far more heterogeneous than those of CC gels, consistent with Sirius Red imaging,
and the scar-like0.3kPa gels also appeared 2–3-fold stiffer than the same gels without collagen
fibers (Figure 2.4Bii). However, such a nominal shift for a stratified material is indicative of a
stiffer material on top of a softer bulk. We calculated therefore a suitable thin-film correction and
also measured gel tackiness for a second estimation of Esurf (see section A.1, Appendix A).
Both measurements suggested Esurf ∼10 kPa, which is far stiffer than the bulk gel. A recent
report showed that extracellular matrix tethering, by varying sulfo-SANPAH concentration, could
influence stem cell fate regardless of hydrogel stiffness (Trappmann et al., 2012). However,
we found that reducing Sulfo-SANPAH reduced Col1 coating density (Figure 2.4C), which may
complicate the reported matrix-tethering effects as they may also be attributed to cell responses
to ligand-density variation (Engler et al., 2004a).
Cells apply tractions predominantly along the matrix surface (Dembo and Wang, 1999),
whereas the AFM probes primarily normal to the substrate. Lateral pulling of the gel surface
with a glass microprobe at constant displacement was therefore used to apply a constant
force on scar-like0.3kPa gels (Figure 2.5). Displacements of microbeads embedded in the
gels exhibited the expected Boussinesq-like profiles (Figure 2.5B,C; also see section A.2,
Appendix A). Displacement profiles far from a fiber bundle were strikingly similar to those
for homogeneous 0.3-kPa gels, whereas profiles closer to fiber bundles appeared similar to
those for homogeneous 10 kPa gels (Figure 2.5Cii). We estimated therefore that Esurf ∼ 0.3
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to 10 kPa for scar-like0.3kPa gels, which highlights the regional rigidity near the fiber bundles.
The imaging and physical measurements therefore suggest that the scar-like matrix is a stiff
fibrous meshwork within a background of otherwise soft, tissue-like matrix. Whether cells would
respond in a scar-like manner, despite matrix heterogeneity, was the next critical question.
2.2.2 ‘Scar in a dish’ impairs cardiomyocyte beating consistent
with heart failure
Following a heart attack, regions of necrotic myocardium that result from acute ischemic injury
are replaced by scars that are too rigid for the heart to contract, causing large decreases in
cardiac output and eventual heart failure. This is a major clinical problem today, and there is
great interest in using cardiomyocytes differentiated from pluripotent stem cells to help replace
damaged myocardium (Laflamme et al., 2007). However, how such cells respond to a scar-
like matrix when engrafting is crucial to understand. Stem cell-derived cardiomyocytes were
therefore seeded onto CC3kPa or scar-like3kPa gels, with 3 kPa chosen as the nominal stiffness
because embryonic heart is mostly collagenous matrix and is ∼1–6 kPa in stiffness (Majkut
et al., 2013; Engler et al., 2008). Collagen-coated tissue culture polystyrene (CC-TCP) was
used as a standard control. After 10 days of culture, the number of beating cells was minimal
on scar-like3kPa gels compared to CC3kPa gels (28% vs 100%) with large differences likewise
in beating frequencies (0.24 ± 0.03 Hz vs. 0.61 ± 0.06 Hz) (Figure 2.6A). Results for CC-TCP
were the same as scar-like3kPa gels, consistent with expectations that heart cells simply cannot
contract rigid matrices and will eventually stop beating.
The handful of cardiomyocytes that beat at high rates on the stiff scar-like3kPa and CC-
TCP substrates exhibited informative beating patterns. TCP is too rigid to contract, but local
regions of some cells did appear to twitch at the normal rate. Likewise, on scar-like3kPa gels,
any cardiomyocyte that was half-attached to a scar-like fiber bundle showed no measurable
contraction on the fibers, while the other half of the same cell beat normally on the CC part
of the substrate (Figure 2.6Bi-iii). Given the sensitivity of beating to substrates, the evident
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nuclear beating (Figure 2.6Biv) suggested that nuclear phenotypes could also emerge in scar-
like cultures. Ultimately, individual cardiomyocytes could not beat when the matrix was too rigid.
These initial findings with cells confirm our physical measurements showing scar-like gels are
regionally soft or rigid, but they also suggest that the overall cell response is dominated by the
rigid regions.
2.2.3 MSCs durotax to the ‘scar in a dish’
MSCs show some therapeutic utility in heart repair (Berry et al., 2006; Hare et al., 2009), and
although mechanisms remain unclear, there is also evidence of homing to the injury site (Orlic
et al., 2001). MSC migration towards a site of injury within tissue will typically involve a large
gradient in stiffness, such as in an infarct border zone (∼9 kPa/mm; Berry et al., 2006; Tse and
Engler, 2011). In several other homogeneous gel systems, various cell types including MSCs
have been reported to ‘durotax’ from soft to stiff matrix (Tse and Engler, 2011; Isenberg et al.,
2009; Raab et al., 2012; Lo et al., 2004). A gradient of increasing scar-like fiber bundles was
therefore made here to resemble a transition from homogeneous soft tissue to a heterogeneous
scar (Figure 2.7A). A PA gel precursor solution was mixed with or without Col1, and drops of
each solution were deposited next to each other; Sirius Red staining confirmed such a gradient
of scar-like fibers over a length scale ( 2–4 mm) that ultimately saturates to a 20–30% area
fraction (Figure 2.7B), similar to that seen in diseased tissue (Pfeffer and Braunwald, 1990;
Turgeman et al., 2008; Mann et al., 2011).
Live cell imaging allowed us to track cells on either side of the transition zone (Figure 2.8A).
Net displacements of cell centroids every 15 min towards either the CC half or scar-like half
were used to calculate a Durotaxis Index (Raab et al., 2012), by counting the net number of
steps a cell takes to move towards the scar-like region. Strikingly, only MSCs migrating in the
transition region exhibited strongly positive net displacements (Figure 2.8B) and Durotaxis Index
(Figure 2.8C) towards the scar-like0.3kPa region. Far from the gradient and in both CC0.3kPa
and scar-like0.3kPa regions, MSCs showed no observable migration bias. A monotonic increase
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in Durotaxis Index with the underlying elasticity contrast (∆E) was previously documented for
vascular smooth muscle cells (Isenberg et al., 2009), and a very similar relationship for MSCs
implies that scar-like0.3kPa gels have an effective Esurf ∼ 10–14 kPa (Figure 2.8Ciii). This
Esurf estimated from cell motility agrees with the maximum Esurf obtained from our physical
measurements (Figure 2.5). Heterogeneity of our matrices did not obscure durotaxis probably
because the turnover and hysteresis of cytoskeletal structures (e.g. myosin IIB) takes hours
(Raab et al., 2012), suggesting a short-term memory (rather than long-term memory; Yang
et al., 2014) in the crawling cells as they average over matrix heterogeneities and ‘remember’
only the stiffer fiber bundles. Moreover, the minimum area fraction of ‘scar’ for imparting a
memory seems low since MSCs durotax into an increasingly heterogeneous scar-like region
with migration results that fit well to findings for homogeneous gels.
Knockdown of myosin IIB (MIIB) in MSCs eliminated durotaxis (Figure 2.8Ci,ii), consistent
with our recent demonstration that MIIB polarizes rearward only on stiff matrices and is
needed for durotaxis where persistent migration increases from soft to stiff (Raab et al., 2012).
Immunostaining and imaging of MSCs on both ends of the soft-to-scar gradient confirmed
the expected MIIB polarization differences as well as increasing expression of α-smooth
muscle actin expression (SMA; Figure 2.9A), which is a myogenic marker for intracellular
tension that is commonly elevated in scarred tissue (Hinz, 2007). However, results for day-
1 versus day-2 showed that MIIB polarization preceded SMA upregulation on the scar-like
matrix (Figure 2.9Aii). Thus, the ‘scar marker’ SMA is not required for early stiffness sensing,
consistent with studies of chemically induced liver fibrosis (Georges et al., 2007). Rearward
nucleus polarization during cell migration on stiffer matrices (Figure 2.9Ai) is also suggestive of
higher contractility in the rear, consistent with MIIB polarization seen recently (Raab et al., 2012).
Among myosin-II isoforms (A, B and C), MIIB accounts for only 5–10% of total myosin-II in MSCs
(Raab et al., 2012), and cell traction forces do not change drastically with MIIB knockdown (Cai
et al., 2006). Interestingly, a cell size-dependent ‘attraction’ to the underlying scar-like fibers was
evident (Figure 2.9B), consistent with a local, myosin-dependent durotaxis in which well-spread
cells exert higher, myosin-IIA-dominated traction forces. Haptotaxis did not contribute because
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MSCs did not spread on scar-like fibers without the additional collagen coating (Figure 2.3A).
To confirm and extend these findings, an additional model for scarred heart matrix was
made. Ventricular myocardium was decellularized and half of the collagen-I-dominated matrix
(Majkut et al., 2013; Figure 2.10) was stiffened by chemical crosslinking (Figure 2.9C). The
apparent E of this 3D matrix determined by AFM (Figure 2.9Cii) approximates the results
above from AFM for CC0.3kPa and scar-like0.3kPa gels (0.3–1 kPa; Figure 2.4Bii). Seeding
of MSCs (transduced with GFP for visualization) showed a uniform distribution along the entire
heart matrix, as verified 4 hrs post-seeding. After 1–2 days, cell numbers were depleted in the
gradient region as a wave of MSCs accumulated in the crosslinked, stiff region (Figure 2.9Ciii).
The findings are consistent with the net effect of durotaxis-based accumulation as illustrated
with the simpler ‘scar in a dish’.
2.2.4 Effective stiffness of ‘scar in a dish’ can be deduced from
cell shape and cytoskeleton
Systematic analyses of cell morphologies and key markers of cytoskeleton uniformly indicate
the scar-like matrix is ∼10–14 kPa with respect to the cell. Most cells spread more on stiffer
substrates (Engler et al., 2006; Rehfeldt et al., 2012), and by fitting a characteristic hyperbola
in response to matrix E (Rehfeldt et al., 2012; Zemel et al., 2010), the scar-like0.3kPa gel has
an effective elasticity (Eeff ) of ∼12 kPa (R2 = 0.98), which is similar to the estimate obtained
from analyses of cell aspect ratio (Figure 2.11Ai,ii). The latter also proved sensitive to myosin-II
inhibition, even on the scar-like matrix. Nuclear shapes also respond similarly to matrix rigidity-
induced contraction (Figure 2.11Aii). Localization of MIIB to the rear of the cell (Raab et al.,
2012) and the expression of SMA are both hyperbolic with E (R2 ≥ 0.97), and once again
indicate that the scar-like0.3kPa gel has an Eeff ∼ 12 kPa (Figure 2.11B,C). SMA incorporation
into stress fibers as well as its increased expression is sustained up to 7 days on stiff matrices
(Figure 2.11Cii,iii), suggestive of commitment to a scar-like phenotype (Tomita et al., 1999).
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2.2.5 Stiffness of ‘scar in a dish’ increases lamin A and MSC
osteo-commitment
Our analyses of striated muscle diseases prone to scarring revealed an increase in lamin A
(Figure 2.1), which is a nucleoskeletal protein implicated in various differentiation and
maturation processes (Swift et al., 2013b; Majkut et al., 2013; Shin et al., 2013). Measurements
of lamin A here likewise showed an increase on stiffer matrices (Figure 2.12A) as early
as 24 hours (Figure 2.12B), which is also consistent with our recent report that lamin A is
mechanosensitive to matrix stiffness (Swift et al., 2013b), likely through cytoskeletal stress
exerted on the nucleus (Swift et al., 2013b; Liu et al., 2014). Knockdown of lamin A followed by
in situ hybridization shows that lamin-A protein levels increase with LMNA transcript numbers
(Figure 2.12C). Lamin A is highly expressed in bone (Swift et al., 2013b), and MSCs injected into
infarcted hearts have sometimes been found to form ossified structures (Breitbach et al., 2007)
that would be detrimental for the beating heart. Lamin A regulates nuclear entry of a retinoic acid
(RA) receptor (RARγ) transcription factor (Swift et al., 2013b) that is known to promote bone
formation (Shimono et al., 2011), while SMA is a product of the serum response factor (SRF)
pathway that also contributes to osteogenesis (Chen et al., 2012). Studies of osteogenesis on
the scar-like matrix were thus strongly motivated. A mechanobiological gene circuit (MGC) is
proposed to formalize the various pathways in Chapter 4 (Figure 2.12D), starting with matrix
stiffness that induces cytoskeletal tension (e.g. myosin II or SMA) that is, in turn, applied to the
nucleus, specifically regulating the stability of lamin A. RARγ-dependent lamin-A expression is
upstream of SMA via SRF (Swift et al., 2013b), while positive mechanical feedback by SMA-rich
stress fibers on lamin A leads to fold changes of both proteins in response to matrix E –– as
modeled by the MGC (Figure 2.12A).
Compared to MSCs on CC0.3kPa gel, culturing MSCs for a week on both scar-like0.3kPa and
CC40kPa gels with osteogenic induction media (OIM) increased Alkaline Phosphatase (ALP)
activity, which is an early marker of osteogenic commitment (Figure 2.13A). Calcification was
also evident on the stiffer matrices based on staining with Alizarin Red (Figure 2.13B). The lack
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of significant Alizarin-Red staining on scar-like0.3kPa gels conforms to the observations that its
Eeff is well below what is needed for MSC osteogenesis either in vitro (Engler et al., 2006) or
in vivo (Berry et al., 2006; Breitbach et al., 2007). In all cases, RA treatment inhibited both ALP
activity and Alizarin-Red staining that is likely due to reduction of stress-stabilized lamin A (Swift
et al., 2013b). The results indicate that the scar-like matrix tends to be osteogenic, and that even
though the vitamin-A derivative RA is normally nM in serum, higher doses of RA agonists show
therapeutic promise for inhibiting calcification of scar tissue.
2.2.6 Lamin-A & MMP9 in progenitor-derived macrophages also
increase with matrix stiffness
Monocyte-derived macrophages are essential in solid tissue remodeling, as exemplified by
regeneration of salamander limbs (Godwin et al., 2013), liver (Ramachandran et al., 2012)
and, to a more limited extent, skeletal muscle (Tidball and Wehling-Henricks, 2007). Distinct
macrophage subtypes and plasticity complicate our understanding of repair (Ramachandran
et al., 2012; Tidball and Wehling-Henricks, 2007; Nahrendorf et al., 2007), and specialized
resident macrophages in various tissue compartments exhibit a spectrum of activation states
(Mosser and Edwards, 2008) that seem, in part, mechanically regulated (Yang et al., 2000;
McWhorter et al., 2013). We hypothesized therefore a differentiation circuit for macrophages
that depends on matrix stiffness and RA (Figure 2.14A) and affects not only lamin-A levels but
also proteases known for roles in liver repair (Ramachandran et al., 2012).
Monocytes differentiate to surface-adherent macrophages by addition of phorbol esters
(PMA) that induce expression of lamin A (Olins et al., 2001) and matrix metalloproteinases
(MMP; Worley et al., 2003), which RA inhibits (Olins et al., 2001; Worley et al., 2003;
Figure 2.14B). As a function of increasing matrix stiffness, PMA increased protein levels of
lamin A and MMP9 (but not of lamin B or MMP2), and subsequent RA treatment generally
suppressed expression (Figs. 2.15 and 2.16). Chromatin immunoprecipitation followed by
sequencing (ChIP-Seq) for the relevant transcription factors (Figure 2.17) confirms binding of
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RA-regulated transcription factors to the LMNA and MMP9 promoters but not to LMNB1/2 nor
MMP2 genes (Allenby et al., 1993). Interestingly, the protein changes versus matrix stiffness
are well-fit by the same hyperbolic responses as those for MSCs (Figure 2.11). This not only
implicates the same underlying gene circuit with respect to matrix sensitivity but also that the
scar-like0.3kPa matrix exhibits — for a cell type distinct from an MSC — an effective stiffness of
Eeff = 10–14 kPa.
2.3 Conclusion
All three cell systems studied here (striated myocytes, MSCs, and macrophages) are not
only relevant to scarring of at least one major human tissue type, striated muscle, but more
importantly all three cell types respond to our heterogeneous scar-like gels as if they are on
much stiffer matrix. The 3D ex vivo decellularized heart matrices developed here exhibit similar
rheological profiles as 2D scar-like gels (Figs. 2.5 and 2.9C), and MSCs durotax on both,
reminiscent of MSC accumulation into scarred tissues (Orlic et al., 2001). MSC migration,
morphology, and protein responses to matrix E indeed reveal a high effective E of the scar-
like0.3kPa gel (Figs. 2.8, 2.9 and 2.11), consistent with the maximum E determined in suitably
analyzed micromechanical measurements (Figure 2.5). ECM micro-architecture is thereby
important to the mechanochemical control of cell fate.
Heterotopic ossification occurs in many tissue contexts, including muscle disease (Mu et al.,
2013) and hip replacement surgery where it is problematic (Kocic et al., 2010). MSC injection
into infarcts (but not normal muscle) can cause calcification (Figure 2.13; Breitbach et al., 2007),
but MSC injection can also improve cardiac performance due to direct repression of fibrosis
(Berry et al., 2006) or indirect immunomodulation (Tomita et al., 1999). MMP secretion by MSCs
is far below that of macrophages, but the changes in phenotype of engrafted MSCs could help
to recruit and modulate reparative macrophages that effectively repress fibrosis. Therapeutic
utility has indeed been shown with macrophages activated ex vivo and injected into infarcted
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hearts (Leor et al., 2006), and MMP9 is specifically implicated in blood stem cell recruitment
for muscle repair (Lolmede et al., 2009). MMP-mediated softening of stiff, fibrotic matrix seems
likely, and co-cultures of MSCs and macrophages in scar-like gel systems and gradients made
here could help clarify mechanistic aspects of the interplay of such important cells.
The fact that scarring occurs only in mature stages of higher animals (Gurtner et al.,
2008), such as Homo sapiens, likely reflects an evolved need to generate a sufficiently
stiff tissue that sustains the large stresses in mature tissues. Tissue injuries initiate broad
chemical and mechanical changes that also serve as homing cues for highly plastic MSCs and
monocytes/macrophages, among other cell types. Lamin-A changes in scarred tissues and
scar-like gels (Figs. 2.1, 2.12 and 2.15) illustrate the plasticity of at least one nuclear protein
that regulates several transcription factors in normal differentiation. For example, lamin-A’s
positive regulation of actomyosin proteins via SRF (Swift et al., 2013b) should help MSCs
contract wounds that myofibroblasts usually close (Hinz, 2007) and also make macrophages
more phagocytic (Tsai and Discher, 2008), which is conducive to resolving fibrosis at least in
liver (Ramachandran et al., 2012). In MSCs, lamin-A levels regulate nuclear entry of RARG,
promoting osteogenesis (Swift et al., 2013b). However, monocytes express RARA as the
major RAR isoform (Hashimoto et al., 1990; Zhu et al., 2001), and so a panel of RAR specific
drugs was tested, revealing that PMA-induced levels of lamin A and MMP9 were significantly
repressed via RARA (Figure 2.18). Such findings can guide novel application of specific
compounds to limit calcification and matrix remodeling in scars.
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2.4 Materials and Methods
2.4.1 Synthesis and functionalization of conventional and scar-
like hydrogels for cell culture
Circular glass coverslips (18-mm diameter, Fisher Scientific) were pre-treated in boiling
ethanol, then RCA solution at 70°C (1:1:3 of 30% H2O2:15N NH4OH:distilled H2O) for 10
minutes each, and functionalized in chloroform solution with 0.1% allyltrichlorosilane and 0.1%
triethylamine for 30 minutes. Varying ratios of N,N’-methylene-bis-acrylamide (Sigma) and
acrylamide solution (40%, Sigma) in distilled H2O were formulated to tune polyacrylamide (PA)
hydrogel stiffness. The PA precursor solution (20 µL) was pipetted on allylsilanated coverslips
with 0.1% ammonium persulfate and 0.1% N,N,N’,N’-tetramethylethylenediamine to initiate
polymerization. To make a 0.3-kPa PA gel, precursor solution consists of 3% acrylamide and
0.07% bis-acrylamide; a 40-kPa PA gel comprises 10% acrylamide and 0.3% bis-acrylamide
(for other formulations, see Table C.1, Appendix C). To create PA gels with embedded collagen
(e.g. scar-like0.3kPa), type I rat-tail collagen (BD Biosciences) was diluted in the PA precursor
solution to a final concentration of 0.4 mg/mL in 50 mM HEPES buffer (pH 8). Gradient gels
were prepared by juxtaposing 2 drops (10 µL) of different precursor solutions on a coverslip.
For MSC durotaxis on CC0.3kPa/scar-like0.3kPa hybrid gel (Figure 2.7), the formulation for
0.3-kPa PA gel was used on both sides, but with pre-mixed collagen-I on the scar-like side
as described above. In order to delineate the regions under the microscope, fluospheres
(1-µm diameter, Invitrogen) were supplemented 0.005% by weight in the soft side, while
collagen fibers in the embedded collagen region were fluorescently immunolabeled. During
polymerization, the gel precursor drop(s) was sandwiched with another pretreated coverslip until
the gel polymerizes. To functionalize the polymerized PA gel, 300 µL of sulfo-SANPAH (Thermo
Scientific, 0.5 mg/mL in HEPES), was added to the gel and exposed for 7 min under 365-nm UV
light (0.7 A, Spectroline Model XX-15A), and was washed twice in distilled H2O. Collagen-I was
diluted to 0.1 mg/mL in HEPES and incubated with the functionalized PA gel at 37°C overnight
on a shaker. Excess collagen was removed and the gel was equilibrated in PBS. Cells were
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plated onto the gels within 24 hours of collagen attachment. Preliminary studies on the efficacy
of sulfo-SANPAH as a collagen-PA gel crosslinker reveal that the collagen-1 concentration (0.1
mg/mL) used in all experiments here, as suggested by previous studies (Engler et al., 2004a; Lo
et al., 2004), saturates all available reactive moieties on the PA gel and are covalently tethered
to the PA gel (Figure 2.4C). These studies altogether indicate saturation of matrix ligands for
cells, thus eliminating the possibility of cell rounding due to low ligand density.
2.4.2 Surface characterization and microrheology of hydrogels
Sirius Red dye (0.1% in H2O, Direct Red 80, Sigma) was stained (for 1 h, rinsed twice in 0.5%
acetic acid) on embedded collagen fibers in the gel to determine their scar-mimesis. Elasticity
of the gel surface, Esurf , was quantified with an Asylum MFP-3D Atomic Force Microscope
(Asylum Research, Santa Barbara), equipped with a microscope stage micromanipulator to
move across the gel during AFM probing. The spatial AFM resolution used here is 1 µm,
which emulates cellular length scales in matrix sensing. A silicon nitride cantilever probe with
pyramidal tip and spring constant of 30–100 pN/nm (MCST, Veeco) was used to indent the
gels. To determine Esurf , the Hertz cone model was used to fit probe deflection curves (up to
1 µm indentation; Domke and Radmacher, 1998). In lateral pulling experiments (Figure 2.5),
glass micropipettes were formed from glass capillaries (1-mm inner diameter, World Precision
Instruments, Sarasota, FL) using a Flaming-Brown Micropipette Puller (Sutter Instrument,
Novato, CA). Pulled micropipettes were tapered at the base, were reopened to a final inner
diameter of 10 µm, and were used to probe the surface of gels, embedded with microbeads
(1-µm diameter FluoSpheres, Invitrogen) as fiduciary markers. The glass probe was constantly
displaced 20 µm parallel to the gel surface, and fluorescent bead displacements were acquired
with a Nikon Eclipse TE300 inverted microscope equipped with Cascade Photometric CCD
camera. Particle Image Velocimetry, an ImageJ plugin, was used to quantify fiduciary bead
displacements after probe pulls. Analysis of displacement profiles is detailed in section A.2 of
Appendix A.
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2.4.3 Cell culture, manipulation, and treatments
R1 mouse embryonic stem cells (mESCs) with cardiac-specific puromycin resistance were
kindly provided by Dr. Rong (University of Pennsylvania, Philadelphia). Fetal bovine serum
(FBS) used in ESC growth and differentiation media was purchased from Hyclone. The
mESCs were cultured on mitomycin-treated mouse embryonic fibroblast (MEF) feeder layers in
supplemented Dulbecco Modified Eagle Medium (DMEM with 4.5 g/L glucose, 100 mM sodium
pyruvate, 100 mM non-essential amino acids; 0.1 beta-mercaptoethanol; 15% Hyclone FBS;
Leukemia Inhibitory Factor, LIF, 1000 u/L). Stem cells were spontaneously differentiated in
embryoid bodies (EB) made from hanging drops of 600 cells per 20 µL in the same DMEM
without LIF. After 2 days in hanging drops, EBs were transferred to rotating cultures for five
days and were then seen to beat spontaneously. To isolate single cardiomyocytes (CMs) from
EBs, 0.05% trypsin-EDTA (Gibco) was used to enzymatically dissociate EBs; the resulting cell
suspension was quenched with differentiation media, pelleted, resuspended, plated on PA gels.
After 24 hr, mESC-derived CMs were further purified by addition of 2.5 µg/mL puromycin in
differentiation media for 7 days.
Racemic blebbistatin (EMD Biosciences) was used at 50 µM for 30 min. For knockdown
experiments, Lipofectamine 2000 (Invitrogen) with 30 nM siRNA was used according to
manufacturer’s instructions. The level of knockdown was assessed by Western blotting after
48 hrs. Myosin-IIB siRNA duplex sequences were obtained from Raab et al. (2012) and
were synthesized by Dharmacon, Inc. Scrambled siRNA was siGENOME Non-Targeting
siRNA #1 (Dharmacon). To minimize experimental variability in durotaxis experiments, both
scrambled and MIIB siRNA-treated MSCs were simultaneously seeded on the hybrid gels and
their migrations were visually discriminated by prior minimal labeling with hydrophobic PKH26
and PKH67 dyes, respectively, according to manufacturer’s (Sigma-Aldrich) instructions. Prior
to plating into decellularized heart matrices, MSCs were transduced at passage 2 (50%
confluency) with 300 PFU of lentivirus per cell for 24 hrs to stably express GFP. For
osteogenesis experiments, sparsely-seeded MSCs (∼2000 cells/cm2) were allowed to reach
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∼70% confluency in normal media prior to addition of osteogenic induction media (OIM,
StemXVivo Osteogenic/Adipogenic Base Media and Supplement, R&D Systems). Osteogenic
cultures, with fresh media every 3–4 days, were done for 1 week or 4 weeks and evaluated
for Alkaline-Phosphatase activity or Alizarin-Red staining, respectively (further details in
Section 2.4.9).
Human THP-1 monocyte suspensions were maintained between 3×105–1.5×106 cells/mL
in RPMI 1640 Medium (Gibco) with 10% FBS and 1% P/S. Differentiation of THP-1 cells into
adherent macrophages was induced by addition of 100 ng/mL phorbol 12-myristate 13-acetate
(PMA) for 2 days. Culture medium (without PMA) is freshly replaced every 2–3 days. Transition
from suspended to surface-adhesive phenotype was concomitant with upregulation of nuclear
lamins and matrix metalloproteinases (Figs. 2.15, 2.16 and 2.18).
Retinoic Acid Receptor (RAR) isoform-selective drugs used for cell treatment were:
Adapalene and CD2665 (Santa Cruz Biotechnology), respective agonist and antagonist drugs
for RARβ and γ isoforms only. All-trans retinoic acid (RA, Fisher Scientific) is a pan-RAR
agonist; AGN-193109 (AGN, Santa Cruz Biotechnology) is a pan-RAR antagonist. Cell-on-
gel cultures were treated with either control solution (0.15% ethanol, 0.15% DMSO in culture
media), or with solution with 1 µM drug.
2.4.4 Proteomics analyses of mouse tissue
Mouse tissue was prepared for analysis as described by Swift et al. (2013b). Approximately 1
mm3 of frozen muscle tissue was ground on dry ice and solubilized in 100 µL 1× NuPAGE
LDS sample buffer (Invitrogen); samples were sonicated on ice before addition of 1% β-
mercaptoethanol, followed by heating to 80 °C for 10 min. SDS-PAGE gels (NuPAGE 4-12%
Bis-Tris, Invitrogen) were loaded with matched quantities of protein (determined by Coomassie
densitometry), with separations run at 100 V for 10 min. followed by 160 V for 25 min. Gel bands
were excised for mass spectrometry (MS) analysis between 60–150 kDa. Details of protein
quantification by label-free MS are described by Swift et al. (2013a), with Elucidator software
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(Rosetta Biosystems) set to search for the hydroxylation modifications that are common in
matrix proteins (proline, asparagine, aspartic acid and lysine, ∆ = +15.995 Da).
2.4.5 Bulk rheology
A cone-and-plate Bohlin rheometer (Malvern Instruments, Worcestershire, UK) was used to
measure the viscoelastic spectrum (elastic modulus, G′ and viscous modulus, G′′) of the
hydrogels as a function of frequency. In order to confirm polymerization had come to completion,
a time sweep test was also performed for 20 minutes with a controlled absolute strain of 1%
at an angular frequency of 1 rad/s. PBS was then added to allow complete swelling of the gel
before a frequency test was conducted from 8 Hz down to 0.0008 Hz at 1.0% strain.
2.4.6 3D reconstruction & photobleaching in confocal microscopy
To visualize both PA gel and collagen-1 (Figure 2.2A), the gel precursor was doped with 0.02%
w/v allylamine (Sigma) for subsequent fluorescein isothiocyanate (FITC, Thermo Scientific)
conjugation, while collagen-1 coating covalently crosslinked with sulfo-SANPAH on the gel
surface is indirectly immunolabeled (Alexa-647 fluorophore, Life Technologies). To delineate
registration of collagen coating on polyacrylamide gels, a confocal microscope (FV1000,
Olympus) equipped with a 40× objective (UPLFLN40XO, N.A. 1.3) was used. Pinhole size
was set at 125 µm to generate an optimal slice thickness of 0.76 µm. Collagen coat is ∼5 µm
on a fully hydrated hydrogel of ∼60–80-µm thickness as determined by 3D confocal stack
reconstruction.
Fluorescence photobleaching was also performed (Figure 2.4Cii) to determine the extent of
immobilization of the collagen-I coating on the gel surface. Fluorescence of the gel surface
was imaged prior to bleaching. The confocal plane was localized on the gel surface as
determined by collagen-I immunofluorescence, and the laser power was increased to maximum
possible amount to photobleach a circular region of interest (ROI) for 60 seconds. Gel
surface with the photobleached ROI was re-acquired for another 5 minutes. Even without
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sulfo-SANPAH crosslinking, photobleached collagen-1 remains relatively stable perhaps due
to interpenetration into the porous gel surface.
2.4.7 Decellularized Embryonic Heart Matrix
Hearts were removed from chicken embryos at embryonic-day 14 (E14) and the left ventricle
wall was isolated and immersed in 1% SDS in deionized water for decellularization. After
shaking overnight at room temperature (RT), the decellularized tissue was placed into 1%
Triton-X in deionized water for 30 min and then equilibrated in PBS with 100 µg/mL penicillin
and 100 µM streptomycin until used for experiments. To make a gradient of crosslinks in the
matrix, the decellularized tissue was fixed on a coverslip and then placed into a chamber such
that approximately one half is immersed in 100% glycerol. After allowing glycerol to penetrate
into the matrix for 30 min, 3 mM of genipin (a fluorescent crosslinker, Sigma) in PBS was added
on top of the glycerol to immerse the other half of the matrix, and was then incubated in the
dark at 37°C for 2 hours. Glycerol was then added to replace the top genipin solution, and the
resulting matrix with a crosslink gradient was washed and stored in PBS with antibiotics prior to
use.
2.4.8 Time-lapse Microscopy
Beating cardiomyocytes were quickly imaged (< 1 h) under HEPES-buffered (10 mM) phenol-
red free DMEM (with 10% FBS and 1% P/S, Gibco) on a temperature-controlled (37 °C)
microscope stage with an inverted microscope (IX-71, Olympus) equipped with a 20× LCACh
objective (N.A. 0.40) and a Cascade CCD camera (Photometrics). Image sequences were
acquired every 0.2 s.
Imaging of MSC migration was done using an inverted Olympus IX-71 microscope with
a 10× objective enclosed in a humidified chamber at 37 °C and 5% CO2, 300 W xenon
lamp illumination, and a high-resolution CCD camera (Photometrics CoolSnap HQ). Deltavision
Softworx software was used for image acquisition at 10-min intervals. ImageJ was used to
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track the center of MSC nuclei in movie sequences, and the summed contour distance traveled
divided by the time was used as our measurement of mean speed. This measurement only
reflects total distance traversed but does not reflect cell persistence. We quantified the bias of
the time-dependent number of steps to the left (L, soft CC0.3kPa region) and to the right (R,
scar-like0.3kPa region) by using the equation adapted from Isenberg et al. (2009):
Durotaxis Index = (R− L)/(R+ L).
If Durotaxis Index = 0, there is no bias to cell migration. If Durotaxis Index = 1, all of the steps are
toward the stiff side. Cells that underwent mitosis and those that migrated out of the trackable
region were included only prior to such events.
To verify the hypothesis that MSCs with spread areas greater than 5000 µm2 (i.e. high
myosin content) sense and track the underlying scar-like fibers (Figure 2.9B), the angle
difference between fitted ellipses that best approximate MSC and collagen fiber shape was
calculated in ImageJ. In time-lapse sequences where MSCs overlap with an immunolabeled
fiber, cells were discriminated based on average spread area during period of overlap and the
respective angles were measured and tracked over time.
2.4.9 Histological analyses of osteogenic commitment
After 1 or 4 weeks in culture with osteogenic induction media (OIM), MSCs on gels were fixed
at RT with 3.7% paraformaldehyde for 20 min and washed thrice in 10 mM Tris buffer (pH
7.2). For 1-week cultures, Alkaline Phosphatase (ALP, early osteogenic biomarker) activity
was visualized by Fast Blue staining. While cells were being fixed, 2 mL of naphthol-AS-
MX phosphate and one pre-weighed capsule of Fast Blue RR Salt (Sigma) were dissolved
with stirring in 48 mL distilled water in the dark (Fast Blue Solution). Fixed cultures were then
immersed in Fast Blue Solution for 30 min, subsequently washed in distilled water twice, and
imaged immediately or mounted in aqueous mounting media for storage.
For 4-week cultures with OIM, Alizarin Red (late osteogenic biomarker) staining was
performed. Cultures were fixed with 10% paraformaldehyde for 10 min, washed with PBS twice,
37
and stained with 2% Alizarin Red S (Sigma) solution for 15 min, all at RT. Staining-solution pH
was pre-adjusted to ∼4.1–4.3 with 0.5% ammonium hydroxide. Samples were then washed
with distilled water and imaged immediately (or stored accordingly). Samples were imaged
using an inverted microscope (IX-71, Olympus) with a 4× objective and a USB-compatible
digital color camera (DC2000M; World Precision Instruments, Inc.) attached to the microscope
c-mount tube. Color images were acquired using ScopePhoto software (ScopeTek) and were
processed in ImageJ by converting to 32-bit black and white images, inverting, and measuring
raw intensities. Osteogenic indices for images from both ALP and Alizarin Red-stained samples
were calculated from these raw intensities, and normalized to cell cultures under serum-only
conditions.
2.4.10 Combined Fluorescence In Situ Hybridization (FISH) and
Immunofluorescence Microscopy
This method was developed with multiple singly-labeled fluorescent RNA probes by Dr. Arjun
Raj (University of Pennsylvania) adapted here to simultaneously detect lamin-A expression in
the mRNA and protein levels in situ. Reagents were kindly provided by Dr. Raj. Detailed probe-
synthesis and hybridization protocols were developed by Raj et al. (2008). Labeled samples
were visualized in the same setup as time-lapse microscopy movie sequences, but with a
100× objective with high numerical aperture to achieve a narrow depth of field and discriminate
diffraction-limited mRNA spots during image processing. Roughly 40 z-stack images per cell
were obtained to fully encompass cell height. Spot counting was performed in ImageJ, by
manually thresholding spot intensities and counting speckles that are in the expected diffraction
limited range of 0.2–0.5 microns in diameter. Counts of mRNA spots reported here may be an
overestimate due to the choice of imaging and image processing. Nonetheless, good mRNA-
protein correlations in LMNA-knockdown experiments (Figure 2.12B) validated the technique.
LMNA siRNA was obtained from Harada et al. (2014) and transfected into MSC cultures with
Lipofectamine as per manufacturer’s instructions.
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2.4.11 Gelatin Zymography
To detect matrix metalloproteinase (MMP) secretion during PMA-induced THP-1 differentiation,
gelatin zymogram gels (Life Technologies) were loaded with conditioned media samples
harvested from THP-1 cultures at desired time points and treatments. Prior to loading
conditioned medium was diluted 1:1 with Tris-Glycine loading buffer (Life Technologies), and
immediately loaded into a well. Loaded gels were run in Tris-Glycine running buffer (Life
Technologies) for 120 min. Cell number was used as normalization.
To visualize MMPs, samples in gels were renatured and developed according to
manufacturer’s instructions (Life Technologies). Finally, gels were stained with SimplyBlue
SafeStain (Life Technologies) and scanned for image processing in ImageJ software. MMP
bands on the gels appeared light on a blue background, where enzymatic degradation of
embedded gelatin occurred.
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Figure 2.1. Mechanics, transcriptional and proteomic profiling of muscular dystrophy
tissue. A, Fibrosis-associated stiffening and heterogeneity is consistently seen across tissues
with abundant collagen such as liver (Georges et al., 2007), lung (Liu et al., 2010) and striated
muscle (Berry et al., 2006; Engler et al., 2007). B, Consistent with earlier findings in adult mouse
tissue (Swift et al., 2013b) and developing chick embryo (Majkut et al., 2013), correlations were
observed between lamin A in the nucleus and the composition of the ECM. Quantification of
matrix proteins in mouse muscle tissue by label-free mass spectrometry (MS). i) The signal
strength of each ECM protein was normalized by lamin B1 to account for cell-density variations
between samples; mdx mouse tissue is shown relative to a control of C57 mouse tissue (y-
axis shows fold-change). A Kruskal-Wallis location equivalence test showed the mdx mouse to
have significantly more lumican, collagen-1 and collagen-3 than the control (p < 0.01; n = 4).
ii) MS measurements also suggested that mdx mice had correspondingly higher lamin A,C
and iii) lamin A-to-B stoichiometry (n = 4, not significant). C, At the transcript level, tissue
samples from patients with muscular dystrophy and mouse muscular dystrophy models showed
higher mean COL1 and (Top) correspondingly higher LMNA, even when normalized to LMNB1,
another nuclear envelope gene; ACTA2, a cytoskeleton gene, is expectedly upregulated in
response to stiffening. Bottom, Transcription factors relevant in mechanotransduction pathways
either scale with (RARG), scale against (NKX2-5), or does not scale (SRF ) with COL1.
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Figure 2.2. Synthesis and characterization of a ‘scar in a dish’. A, (Top panel) Schematic
of free radical polymerization of a polyacrylamide (PA) hydrogel and functionalization with
collagen-I (Col1) matrix. (Top, right) PA gel (green) with coated Col1 (CC, red) reconstructed
from confocal image stacks (365 µm × 365 µm surface, ∼80 µm height). (Bottom panel)
Incorporating 400 µg/mL of Col1 during polymerization creates an embedded-Col1 (EC) PA gel
that mimics a scar-like matrix. (Bottom, right) Pore-size directed fibrillogenesis of EC (green)
in CC (red) PA gel. Most Col1 fibers localize near the surface (arrowhead), while some are
embedded (arrows). B, (Left) Top view of EC-PA gel with 1-µm fluorescent beads (red) to
delineate gel surface. (Right) EC fibers (green) localize as a heterogeneous thin film within
∼10 µm near the gel surface (arrow). C, Schematic: EC fibers in the same focal plane as
beads settled on the gel surface. Immunolabeled EC fibers (top, left) stain positive for Sirius
Red (top, middle). Higher magnification of Sirius Red-positive EC fibers (top, right). CC gels
(bottom) have no significant Sirius Red staining, as revealed by line intensity scans (bottom,
right). Scale bars, 100 µm.
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Figure 2.3. Embedded collagen is stable but does not induce cell spreading alone on
soft gel. A, i) MSC cell area (mean ± s.e.m.) on soft (CC0.3kPa) and stiff (CC40kPa) gels are
significantly higher than on scar-like EC gel without CC (EC-only 0.3kPa gel). ii) Myosin IIA
(MIIA, green) and Collagen-1 (Col1, red) immunofluorescence of MSCs on gels. ∗p < 0.05,
∗∗∗p < 0.001, compared to cells on CC0.3kPa gel. B, i) Immunofluorescence images of α-
smooth muscle actin (SMA, red) in MSCs on scar-like0.3kPa gel cultured for 2 (left) and 7 (right)
days show that EC (green) is stable in the gel. ii) Cell number (blue) increases from 2 to 7 days,
while SMA/cell and embedded Col1 remains the same. ∗∗∗p < 0.001, compared to 2 days on
scar-like0.3kPa gel. Scale bars, 100 µm.
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Figure 2.4. Bulk and surface rheology, and functionalization of PA gel. A, i) Time-sweep
measurements of bulk elastic moduli of various PA gels; embedding collagen-1 (0.4 mg/mL;
scar-like0.3kPa, green) did not augment the nominal elastic modulus of 0.3 kPa (blue). ii)
Bulk elastic (G′) and viscous (G′′) moduli of PA gels measured via cone-plate rheometry at
frequencies (0.0008–8 Hz) and strain (1%) that mimic cell traction forces (grey area; Engler
et al., 2004a). B, Atomic force microscopy (AFM) measurements of i) E of bare PA (green)
and CC-PA (red) gels. ii) (Top panel) AFM-derived elasticity maps (40 µm×40 µm) of gel
surfaces. (Bottom)E values of CC0.3kPa gels (blue), scar-like0.3kPa (meanE ≈ 0.8 kPa, green),
and CC40kPa (red) gels. Adhesion (grey) and thin-film corrections (black) predict an order-of-
magnitude higher stiffness (see Appendix A.1). C, i) (Left) Covalent Col1 attachment on a 3-
kPa PA gel depends on Sulfo-SANPAH. Bound Col1 is measured via immunofluorescence from
confocal stacks through the gel. (Right) Absence of Col1 (only Col1 Antibody) shows some
Sulfo-SANPAH binding and diffusion of fluorescent antibodies in the gel. ii) Photobleaching of
immunolabeled Col1 coated via covalent crosslinking (red) or pure adsorption (blue) showed no
recovery.
43
0 40 800
5
10
15
20
Distance from Probe Loading Point,  r (µm)
Di
sp
lac
em
en
t (µ
m)
0 40 800
5
10
15
20
Di
sp
lac
em
en
t (µ
m)
0 40 800
5
10
15
20
Di
sp
lac
em
en
t (µ
m)
A
scar-like0.3kPa
1.0
0.5
0.0 D
isp
la
ce
m
e
n
t (n
or
m
.)
stiff
soft
n = 19 n = 6 n = 10
B
i)
ii)
CC CCC
pulling far
from fiber
pulling
against fiber
glass probe
Fiber
Bundle
Fiber
Bundle
CC scar-like CC
0
5
10
15
20
25
 
a ,tne
mecalpsi
D .xa
M
  
( μ
)
m
 
 Exponential Fit
0
200
400
 
 Boussinesq Fit
a ,
t n
at
sn
oc
 q
se
ni
ss
uo
B
*
*
* *
0
B
10kPa0.3kPa0.3kPa
0.3kPa 10kPa
Figure 2.5. Lateral pulling microscopy reveals the heterogeneity of scar-like0.3kPa gel.
A, Lateral pulling in scar-like EC gels indicate heterogeneous Boussinesq-like displacement
profiles by tracking movement of embedded microbeads in the gels. B, Fit constants of surface
pulling profiles assuming exponential decay (red, a0e−br) or classic Boussinesq decay (black,
aB/r; Landau and Lifshitz, 1986). Pulling profiles of scar-like0.3kPa fibers behave similar to
those of CC10kPa gels. ∗p < 0.001 (red), 0.05 (black); compared to CC0.3kPa gel. C, i)
Representative lateral pulls on scar-like0.3kPa (left), CC0.3kPa (middle) and CC10kPa (right) gels.
ii) Pulling against an EC fiber bundle in scar-like0.3kPa gel shows smaller bead displacements
(left, cyan and grey) similar to a stiffer 10-kPa gel (right). Pulling far from a bundle (left,
magenta) has a displacement profile similar to a 0.3-kPa gel (center). Grey curves are averaged
profiles from n pullings. Scale bar, 10 µm.
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Figure 2.6. Stem cell-derived cardiomyocytes beat less on scar-like gel. A, Decreased
beating rate of embryonic stem cell-derived cardiomyocytes (SCD-CM) on scar-like3kPa and
CC-Tissue Culture Plastic versus CC3kPa PA gel (n = 13–40 cells, ∗p < 0.05 when compared
to CC3kPa gel). Unfilled data points indicate cells are only partially beating. Solid lines indicate
means, excluding unfilled points. B, i) A half-beating SCD-CM on scar-like3kPa gel, standard
deviation of movement (red) shows only the bottom half is beating, away from the region of
scar-like fibers (yellow). Scale bar, 20 µm. ii) Kymographs along solid lines drawn on beating
(blue) and non-beating (black) halves of the cell. iii) Cell edge displacement cycles over time on
the beating half (blue), while it remains static on fiber-rich half (black). iv) Nuclei also contract,
which could change nuclear phenotype.
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Figure 2.8. MSC durotaxis on a gradient of scar-like fibers. A, Normalized migration
trajectories and final positions (squares) of scrambled or myosin IIB-siRNA–treated MSCs on
CC0.3kPa/scar-like0.3kPa hybrid gel after 20 hrs of imaging. Durotaxis occurs if more cells move
to scar-like0.3kPa side (right) more than the CC0.3kPa side (left). B, Net positive displacement
(mean ± s.e.m.) of MSC migration in the transition region toward scar-like0.3kPa region over
time. Statistical difference between scrambled (green) and myosin-IIB knockdown (red) was
determined by two-way analysis of variance with Tukey’s HSD test at α = 0.05 significance
level. C, i) Durotaxis index over time of MSCs treated with either scrambled (red) or nonmuscle
myosin-IIB siRNA (siMIIB, green) on the ‘Transition’ region of the hybrid gel. No significant
change in mean speed was seen in both scrambled (0.38 µm/min) and siMIIB-treated MSCs
(0.40 µm/min). ii) Average durotaxis indices (mean ± s.e.m.) of scrambled and siMIIB-treated
MSCs on various regions of the hybrid gel (∗p < 0.05, when compared to siMIIB). Inset:
Western blot of siRNA-treated cells indicating 75% reduction of myosin IIB. iii) Durotaxis index
versus effective elasticity change ∆E on the different hybrid hydrogel systems. The monotonic
increase of Durotaxis Index with increasing gradient strength has been found previously for
vascular smooth muscle cells (VSMC, Isenberg et al., 2009); thus, ∆E for CC0.3kPa/scar-
like0.3kPa hybrid gel fits around ∼10–14 kPa.
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Figure 2.9. Human MSCs home toward a ‘scar in a dish’ and crosslinked heart matrix ex
vivo. A, i) Immunofluorescence images of myosin IIB (MIIB, green) and α-smooth muscle actin
(SMA, red) at 1 and 2 days after seeding MSCs on the hybrid gel. DNA, blue. ii) Kinetics of SMA
(red) and MIIB rearward polarization (green) of MSCs on CC0.3kPa (circle) or scar-like0.3kPa
(square) side of the transition region (n = 34–89 cells). ∗∗p < 0.01, when compared to CC0.3kPa
side of the gradient. B, i) Alignment between a migrating MSC and an EC fiber based on the
angle difference, θ, of their respective major axes. ii) Real-time tracking of θ in small MSCs
(mean cell/nuclear spread area <5000/<400 µm2, n = 8 cells) and iii) big MSCs (>5000/>400
µm2, n = 8 cells). C, i) (Left) Decellularized strip of a chick embryonic day-13 left ventricular
wall supported on a coverslip, is half-dipped in a solution of a fluorescent protein-crosslinker,
Genipin. (Right) MSCs expressing GFP (green) migrate within the matrix. Scale bar, 50 µm.
ii) Gradient in Genipin-fluorescence intensity for the indicated region matches the measured
gradient in apparent matrix elasticity measured by AFM. iii) MSCs in the ex vivo matrix are
plated homogeneously, but after 1–2 days, cells accumulate on the highly cross-linked side of
the matrix.
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Figure 2.10. Matrix composition of decellularized embryonic chick heart. Decellularized
day-13 embryonic chick heart that was trypsin-digested and sequenced in Mass Spectrometry
revealed the compositional breakdown of extracellular matrix proteins, which was dominated by
Collagen-1 based on total peptide ion current. Scale bar, 2 mm.
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Figure 2.11. Scar-like0.3kPa gel exceeds the threshold for matrix stiffness-dependent
MSC response despite heterogeneity. Morphological and cytoskeletal effects of matrix
elasticity, E, are fitted with a hyperbolic equation: A + BE/(Em + E) using a characteristic
elasticity constant, Em = 9.2 kPa (Rehfeldt et al., 2012). A, i) Matrix elasticity-dependent cell
(A = 3797 µm2, B = 5064) and nuclear (inset; A = 360 µm2, B = 191) spread area and ii) aspect
ratio are quantified (mean ± s.e.m.) from myosin-IIA immunofluorescence staining of MSCs
cultured for 2 days on gels. Nucleus shapes (top) are derived from DNA-stained nuclei. Myosin-
II ATPase activity was inhibited with blebbistatin (50 µM, red) for 30 minutes prior to fixation.
B, i) Quantification of rear/front immunofluorescence intensity (mean ± s.e.m.) of myosin IIB
(MIIB; A = 1.29, B = 0.96) and F-actin. ii) MIIB polarizes toward the rear of a migrating MSC on
both scar-like0.3kPa and CC40kPa gels, while F-actin (red) remains ubiquitous and non-polarized.
C, i) Quantification of immunofluorescence staining (mean ± s.e.m.) of α-smooth muscle actin
(SMA; A = 1, B = 1.17) 2 days after cell seeding. ii) SMA (green) incorporates into stress fibers
over 7 days on both scar-like0.3kPa and CC40kPa, but not on CC0.3kPa. DNA, blue. iii) Western
blot of SMA in MSCs cultured for 7 days on the gels. Goodness of fits, R2 ≥ 0.95. Scale bars,
100 µm.
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Figure 2.12. Local matrix stiffening couples lamin-A and α-smooth muscle actin
(SMA) upregulation, as modeled in the Mechanobiological Gene Circuit. A, Quantitative
immunofluorescence of SMA and lamin-A expression in MSCs cultured for 7 days on gels
(mean ± s.e.m.) revealed tight coupling of cytoskeletal and nucleoskeletal tension as predicted
by the Mechanobiological Gene Circuit (MGC) model (dashed line, see Chapter 4). Inset:
Representative immunofluorescence images of lamin A. B, Kinetics of i) total lamin-A and
ii) serine-22 phosphorylation levels (pSer22/Lamin-A) on soft vs stiff gels. C, Combined
fluorescence in situ hybridization (FISH) and immunofluorescence (inset image) of MSCs
showed lamin-A mRNA (LMNA, red) spot counts correlate with protein expression (green).
(Inset plot) LMNA normalized to GAPDH mRNA spots (blue) indicate extent of knockdown.
Scale bars, 10 µm. D, MGC predicts that scarring, which leads to local increases in matrix
stiffness, can couple and stress-stabilize cytoskeletal and nucleoskeletal tension. Retinoic acid
(RA) disrupts stress-stabilized lamin-A (and downstream-SMA) assembly through retinoic acid
receptor-γ (RARG) (Swift et al., 2013b; Figure 2.13).
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Figure 2.13. Matrix stiffness, but not retinoic acid (RA), induces MSC osteogenesis. A,
MSCs on gels cultured in osteogenic induction media (OIM) with or without RA (1 µM) for
1 wk and stained for Alkaline Phosphatase (ALP), an early marker of osteogenic commitment.
B, MSCs on gels cultured for 4 wks and stained for Alizarin Red, a late marker for bone.
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treated (UT) scar-like0.3kPa gels. Scale bars, 100 µm.
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Figure 2.16. Matrix stiffness, but not Retinoic Acid (RA), also induces MMP9 in
monocytes/macrophages. A, Gelatin zymography of conditioned media collected from 2-
day PMA-stimulated THP-1 cells and conditioned media spiked with or without RA (1 µM) from
day 3–5. B, MMP9 enzyme (92 kDa), but not MMP2 (72 kDa), is upregulated upon PMA
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Figure 2.18. Retinoic Acid (RA), through RARα isoform, reduced lamin A,C and
MMP9 in monocyte-derived macrophages. A, A panel of RAR agonists and antagonists
were used to deduce RAR-isoform specific regulation. THP-1 monocytes were induced to
differentiate (or left untreated, UT) with PMA (100 ng/mL) for 2 days with or without RAR
specific drugs. B, Gelatin zymogram gel of conditioned media from different conditions to
determine matrix metalloproteinase (MMP) expression as THP-1 differentiates. MMP9 was
significantly upregulated after 2-day PMA induction but is reduced with RA treatment, via RARγ.
MMP2 remained at basal activity. C, Lamin-protein levels were checked by Western blotting,
implicating RARα as the major isoform that regulates lamin A,C but not lamin B.
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Chapter 3
Role of a matrix stiffness-sensitive
repressor, NKX2.5, in stem cell
plasticity
Portions of this work are under peer-review in Nature Materials.
Proteomics analyses of cell lysates were performed by Sangkyun Cho.
Microarray analyses of cell-on-gel cultures were performed by Dr. Amnon Buxboim.
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Abstract
An adherent cell responds to matrix stiffness by activating mechanotransduction pathways to
turn on genes that support mechanical stress. Here, we show a novel role of NKX2.5 as a
mechanosensitive repressor of α-smooth muscle actin (SMA), a common fibrosis and cell-
tension marker. A repressor of SMA transcription, NKX2.5, translocates slowly from nucleus
to cytoplasm in response to matrix rigidity, but nuclear-localized mutants of NKX2.5 override
matrix-stiffness sensing with suppression of SMA and cell spreading. MSCs cultured for weeks
or longer on rigid substrate reinforce a ‘mechanical memory’ by decreasing NKX2.5, thus
stabilizing an SMA-high, scar-like phenotype. Interestingly, matrix stiffness also downregulated
collagen-1 synthesis as it upregulated contractility in MSCs. This phenytopic response was
also observed by inhibiting the TGF-β signaling pathway, which is known to modulate matrix
synthesis. TGF-β inhibition accelerated NKX2.5 nuclear exit and degradation, illustrating how
matrix synthesis and contractility is decoupled and how mechanical memory is developed in
MSCs.
3.1 Introduction
Morphological tissue changes during development are often accompanied, if not because of,
mechanical changes. Living cells that comprise tissue are capable of actively sensing and
responding to forces from its microenvironment, by which mechanotransduction of these signals
into the cell ultimately affects cell and tissue fate. Tracking the transcriptomic changes from
pluripotent stem cells (embryonic or induced) to terminally differentiated fibroblasts indicates
systemic increases in structural genes of the extracellular matrix, cytoskeleton, and the nuclear
lamina (Figure 3.1). The multilineage plasticity of stem cells, even after in vitro culture
(Pittenger et al., 1999), has provided a platform to elucidate a milieu of factors that control
differentiation. For example, MSCs can be directed to a specific lineage on matrix-functionalized
hydrogels that mimic the typical stiffness of a mature tissue (Engler et al., 2006). Induced
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pluripotent stem cells have gained increasing utility over embryonic counterparts not only in
tissue regeneration efforts – particularly for soft tissues like brain (Karumbayaram et al., 2009;
Wang et al., 2011) and liver (Sullivan et al., 2010; Liu et al., 2011b) – but also in elucidating the
pathogenesis of aging disorders (Liu et al., 2011a).
Cell-based therapies, such as injecting autologous MSCs into myocardial infarcts (Tomita
et al., 1999; Orlic et al., 2001; Berry et al., 2006), are promising perhaps in their
immunomodulatory properties, but they also pose some risks (Breitbach et al., 2007) due to a
lack of understanding in their unique response to the mechanochemical milieu of a fibrotic scar.
In contrast to embryonic healing, TGF-β signaling is dysregulated in adult tissue injury (Leask
and Abraham, 2004). Resident fibroblasts are activated to myofibroblasts upon TGF-β-induced
nuclear translocation of SMAD2/3, which binds to collagen and SMA genes (among many
others) to generate a highly tensed cellular phenotype (Heldin et al., 1997). Cellular tension
and a stiff matrix synergize to activate TGF-β from its latent, matrix-bound complex (Wipff
et al., 2007), creating a positive feedback loop of matrix hypersecretion and hypercontractility –
ultimately leading to a stiff, fibrotic scar. Therapeutic interventions that inhibit TGF-β signaling
via neutralizing antibodies (Hinz et al., 2001; Biswas et al., 2007) or pharmacological treatments
(Leask and Abraham, 2004) lead to decreases in SMA and collagen production by fibroblasts.
Ubiquitous (SRF, YAP/TAZ, RARG) and tissue-specific (MYOD, NKX2-5, CBFA1)
transcription factors known to potentiate mechanotransduction did not significantly change
mRNA levels during development (Figure 3.1) or with matrix stiffness, at least in MSCs
(Figure 3.2A). SRF (Miralles et al., 2003) and YAP/TAZ (Dupont et al., 2011) has been shown
to modulate cell spreading and adhesion on stiffer matrices, while NKX2.5 is largely implicated
in the specification of the contractile machinery in cardiac tissue (Kasahara and Izumo, 1999).
TGF-β-dependent signaling has also been implicated in enhancing cardiac-specific activity of
NKX2.5 (Lien et al., 2002). A transcription factor that does not change its expression levels,
while its downstream targets do in response to matrix stiffness, hints at intracellular processes
such as posttranslational or structural modifications that affect its function. For example, nuclear
SRF binds effectively on its DNA target only when MAL/MKL1 is released upon actin assembly
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and translocates into the nucleus to associate with SRF (Miralles et al., 2003). More recently,
nuclear entry of RARG in MSCs on stiff matrices has been implicated to modulate levels of the
mechanosensitive nucleoskeletal lamin A protein (Swift et al., 2013b).
In both disease and development, mechanical changes feed back into cell fate. But cells
can also remodel their immediate microenvironment, which complicate various in vitro efforts,
especially three-dimensional models where factors that cells secrete are hard to characterize.
Here, we used hydrogel substrates with a well-defined adhesive matrix to elucidate the effects of
matrix stiffness on the matrix-synthetic and contractile abilities of MSCs. Through bioinformatics
analysis of matrix versus cytoskeletal genes, we uncovered a novel role of NKX2.5 as a
mechanosensitive repressor of matrix stiffness-directed stem-cell response, especially in long-
term mechanical memory induction.
3.2 Results and Discussion
3.2.1 MSCs downregulate collagen-1 synthesis as they become
more contractile
First, systems-level profiling of the effects of matrix stiffness on contractility and matrix-
synthetic ability of MSCs was performed. Transcriptomic analyses of MSCs cultured on stiff
(40 kPa) versus soft (0.3 kPa) collagen-1-coated gels revealed a negative correlation between
cytoskeleton and matrix genes. Genes that are relevant to cytoskeletal contractility are generally
more abundant than the extracellular matrix genes (Figure 3.2A, left column). Furthermore,
intracellular tension markers such as ACTA2 and CALD1 (for proteins, SMA and caldesmon,
respectively) are upregulated 2-fold on stiffer gels, while matrix genes for collagens type 1
and type 6 decreased (Figure 3.2A, right column). The observation that collagen synthesis
is downregulated as MSCs become contractile on stiff gels was then confirmed with mass
spectrometry analysis in the 110-160 kDa range (Figure 3.2B) as well as with Western blot
(Figure 3.3A) and immunofluorescence (Figure 3.3B). This was also observed independent of
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matrix type (Figure 3.4). Contractile proteins detected in MS (e.g. actinins) that fall within
the 110–160 kDa range were also found to be upregulated (Figure 3.2B), consistent with
transcriptome profiling (Figure 3.2A).
Consistent with the role of stem cells in tissue homeostasis, a less matrix-synthetic yet
contractile phenotype might be beneficial, particularly in wound healing, as mimicked by the
scar-like0.3kPa gel described in Chapter 2. In contrast, fibrosis is principally due to activated
fibroblasts (i.e. myofibroblasts) that concomitantly increase SMA expression and collagen matrix
deposition, both of which can be downregulated by inhibition of TGF-β signaling (Kapoun
et al., 2006). Indeed, MSCs treated with TGF-β1 increased in SMA and collagen-1; yet
unlike myofibroblasts, MSCs treated with a TGF-β receptor inhibitor (SB505124, 10 µM) almost
completely abrogated collagen-1 but did not affect SMA (Figure 3.5) –– a phenotypic equivalent
to the response of MSCs to matrix stiffness (Figs. 3.2 and 3.3). Therefore, TGF-β is sufficient
but not necessary for SMA expression in MSCs. This response is also seen in hepatic stellate
cells (Olsen et al., 2011), which also possess stem-cell characteristics.
3.2.2 Matrix stiffness modulates NKX2.5 localization
We looked into transcription factors that bind differentially to contractility- and matrix-related
genes that could explain this decoupling response. Through bioinformatics-based comparative
promoter analysis of representative genes for cytoskeleton (ACTA2) and matrix (COL1A2)
(Table 3.1A), we found transcription-factor families with the highest binding to ACTA2 promoter
(but not to COL1A2 promoter) that contained homeodomains and POU domains; SMADs of
the TGF-β pathway and SRF are common to both promoters (Table 3.1B). Homeodomain-
containing NKX2.5 ranked highest among transcription factors that bind only on ACTA2 but
not on COL1A2 promoter. In the first ∼1200 base-pairs upstream of ACTA2 transcription
start site, there are at least 4 predicted binding sites for the NKX family, and 5 sites for the
SRF family (Figure 3.6A). Among the NKX family of transcription factors, NKX2.5 is also
the most abundantly expressed in the body (Kasahara et al., 1998) and particularly in MSCs
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(Figure 3.6B); it is also moderately expressed relative to other genes (Figure 3.2A).
To determine whether NKX2.5 plays a role in the matrix-stiffness response of cells,
embryonic chick cardiomyocytes beating on soft or stiff gels were immunostained and imaged
for Nkx2.5, which was predominantly nuclear (Figure 3.7). However, total Nkx2.5 increased in
highly striated cardiomyocytes found on stiff-gel cultures, largely due to increased cytoplasmic
levels (Figure 3.7B). We looked into the predicted abundance of NKX2.5 in human MSCs
(Figure 3.6) and observed post-translational modifications as evidenced by band shifts from
the expected 35 kDa band (Figure 3.8A). To confirm that this was not an artifactual effect of a
polyclonal antibody that detects mouse, chick and human versions, we overexpressed Nkx2.5
(mouse) in an A549 human cell line and detected highly abundant peptides unique to Nkx2.5
(Figure 3.8B,C). As with endogenous NKX2.5 in MSCs, overexpressed Nkx2.5 was also post-
translationally modified (Figure 3.8B).
NKX2.5 was likewise nuclear-localized in MSCs on soft gels, but unlike cardiomyocytes,
it was predominantly cytoplasmic on stiff gels (Figure 3.9). We have also uncovered an
interesting matrix-stiffness response of NKX2.5 that spans several days. Unlike myosin IIB
(Figure 2.9Aii) and lamin A (Figure 2.12B) that respond in <1 day to matrix stiffness, SMA
only increased significantly (by 2-fold) in two-day MSC cultures on stiff matrix compared to
soft matrix (Fig. 2.9Ai and Fig. 2.11C), while prolonged 7-day cultures led to further SMA
upregulation (up to 8-fold) on stiff matrix, which was not observed on soft matrix (Figure 2.12A,
Figure 3.10). Nuclear exit of NKX2.5 in MSCs appeared slower than typical SRF mechano-
activation, which can respond within minutes (Esnault et al., 2014), suggesting that SRF could
drive initial expression of SMA while NKX2.5 is involved in the maintenance of SMA expression
for longer cultures. Transcript profiling of MSCs cultured for 1 day (Figure 3.2A) revealed
stiffness-driven increases in ACTA2 and CALD1 but not NKX2-5 or SRF (which also promotes
its own expression). Total NKX2.5 protein levels also did not change with matrix stiffness up
to 7 days (Figure 3.10, inset), highlighting an important role for transcription-factor localization
rather than its abundance.
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3.2.3 A long-term rigid-matrix phenotype: nuclear exit of NKX2.5
Given the decreases in NKX2-5 levels in chronic diseases such as muscular dystrophies
(Figure 2.1C), we hypothesized that cytoplasmic enrichment of NKX2.5 in MSCs on
rigid substrates would be followed by its degradation (Figure 3.11A). First, to determine
whether NKX2.5 is functionally sufficient to repress SMA’s response to matrix stiffness, we
overexpressed wild-type or mutant forms of Nkx2.5. Shuttling of Nkx2.5 to the nucleus has
been shown to be controlled by a putative nuclear localization sequence (NLS) near the
homeodomain region of the protein (Kasahara and Izumo, 1999); mutations to the NLS of
Nkx2.5 determine its subcellular localization (Figure 3.11B). We overexpressed wild-type and
NLS-mutant NKX2.5 in A549 cells and observed that only the NLS3 mutant, with alanine
replacement of all residues, prevented nuclear localization (Figure 3.11C). More importantly,
overexpression of the nuclear-localized wild-type, NLS1, or NLS2 mutants in MSCs repressed
SMA, reduced stress fibers, and ultimately reduced cell and nuclear spread areas on rigid
substrate (Figure 3.12). In clear contrast, the cytoplasmic NLS3 mutant maintained the rigid-
substrate phenotype.
An endogenous NLS sequence in NKX2.5 implies that its nuclear exit on rigid matrix must be
an active process. NKX2.5 in stress fibers (Figure 3.13A) and in lamellipodia co-localized with
myosin phosphatase-1 (MYPT1; Figure 3.13B) supports recent evidence of MYPT1-dependent
nuclear exit of NKX2.5 in embryonic stem cells (Ryan et al., 2013). It has been suggested that
nuclear exit of Nkx2.5 requires ROCK-induced phosphorylation of MYPT1 (Ryan et al., 2013),
which prevents myosin-IIA filament disassembly (Eto et al., 2005) that is induced, for example,
by matrix stiffness (Raab et al., 2012). Thus, direct binding of phosphorylated MYPT1 to
NKX2.5 may account for the observed nuclear exit and subsequent stress-fiber localization. The
effect of cytoskeletal tension in NKX2.5 translocation from nucleus to cytoplasm was tested by
inhibiting myosin-generated cytoskeletal forces with blebbistatin. Within several hours, nuclear
levels of NKX2.5 increased and SMA subsequently decreased (Figure 3.14A). Transcript
profiles following 24-h blebbistatin treatment of MSCs on rigid substrates (CC11kPa and tissue
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culture plastic, TCP) further showed the expected repression of ACTA2 but in the absence of
reproducible changes in cardiac-specific transcripts downstream of NKX2.5 (Figure 3.14B). As
expected (Swift et al., 2013b; Dupont et al., 2011), blebbistatin also decreased YAP1 and SRF
target genes (slightly), with the latter likely to also contribute to the >50% decrease in SMA at
both protein and transcript levels.
Finally, on rigid substrates where drugs such as blebbistatin rescue nuclear depletion of
NKX2.5, the long-term trend is a major decrease in NKX2.5, as observed in high-passage MSCs
(Figure 3.15). SMA might increase slightly, but it certainly does not decrease (Figure 3.15B,
rightmost bar). One other study that has described NKX2.5 in MSCs focused on the cardiogenic
potential of MSCs grown on either TCP or gel-bound matrix derived from healthy or infarcted
hearts (Sullivan et al., 2014), and the authors described a tendency in immunoblots (that show
an atypical high molecular weight band) for decreased NKX2.5 in MSCs on stiffer substrates
(25 kPa > 40 kPa > TCP). Functional significance of NKX2.5 in MSCs has not been examined
previously, and any possible relation to NKX2.5 to SMA in MSCs has not been suggested
– especially since SMA is not part of the cardiogenic program. Because we show that
translocation of NKX2.5 out of the nucleus can be modulated by cytoskeletal interactions,
including stress fibers, the long-term effects of matrix stiffness (e.g. fibrosis) ultimately favor
degradation of NKX2.5 and maintenance of an SMA-high phenotype as a form of ’mechanical
memory’.
3.2.4 Crosstalk of NKX2.5 and SRF with TGF-β pathway decouples
SMA & collagen-1 expression
Inhibiting TGF-β with SB505124 for 1 day also reduced nuclear-NKX2.5 levels on both soft and
stiff gels (Figure 3.16A). Plotting SMA intensity with nuclear localization of NKX2.5 suggested
a universal repressor-inhibition curve (Figure 3.16B). Interestingly, sustained TGF-β inhibition
(3 days) decreased total NKX2.5 levels, concomitant with an increased SMA expression
(Figure 3.16C), which further demonstrated the equivalent effects of matrix stiffness and TGF-β
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inhibition.
Tissue stiffening is typically accompanied by elevated TGF-β signaling, as in fibrosis. It has
been suggested that serum-induced SRF is a nuclear repressor of TGF-β signaling, by inhibiting
the DNA binding of Smad3/Smad4 complex (Lee et al., 2007). Matrix stiffness-induced actin
polymerization also increases SRF activity (Swift et al., 2013b; Miralles et al., 2003), with SRF
upregulating contractility genes like ACTA2 (Esnault et al., 2014). Here, cell-on-gel cultures
have basal serum-derived TGF-β and SRF activity; on stiffer matrices, however, a higher SRF
activity (Swift et al., 2013b) coupled to a cytoplasmic NKX2.5 (Figure 3.9) may have inhibited
TGF-β-induced expression of collagen-1 (Figure 3.3), whilst promoting SMA transcription and
translation (Figure 3.17A). TGF-β has also been shown to modulate NKX2.5 expression
in MSCs via SMAD (Li et al., 2008). Indeed, inhibiting TGF-β signaling reduced nuclear
levels (Figure 3.9) and when sustained, total NKX2.5 levels as well (Figure 3.10) – effectively
promoting a highly contractile, yet low matrix-synthetic phenotype in MSCs (Figure 3.17B).
3.2.5 Other modifications of NKX2.5
We have also observed NKX2.5 in the Golgi apparatus (via co-localization with fluorescent
wheat germ agglutinin, WGA), but not in the endoplasmic reticulum (via co-localization
with procollagen-1) (Figure 3.18A). WGA stains for proteins modified with O-linked N-
acetylglucosamine (O-GlcNAc, 203 Da) typically seen in the Golgi apparatus. O-GlcNAc
modifications, in general, have been implicated as a rapid stress sensor (Hart et al., 2007). O-
GlcNAcylation of Nkx2.5 could affect its function and turnover and was recently linked to diabetic
cardiomyopathy (Kim et al., 2012), which is characterized by excessive O-GlcNAcylation (Clark
et al., 2003). This modification, however, does not account for the multiple molecular weight
shifts observed in Western blots (Figure 3.8).
Other studies have suggested that Nkx2.5 activity can be regulated by the attachment of
small ubiquitin-like modifier-1 (SUMO-1, ∼11.5 kDa) on lysine residue-51 (Wang et al., 2008),
whereas preventing such leads to congenital heart defects during development (Kim et al.,
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2011). In MSCs, cells that had smaller spread area (and hence, nuclear-localized NKX2.5)
also had higher nuclear SUMO-1 intensities (Figure 3.18B). Whether localization mutants
of NKX2.5 have varying SUMO-1 levels and whether nucleocytoplasmic shuttling of Nkx2.5
involves SUMOylation pathway warrant further investigation.
3.3 Conclusion
Matrix stiffness and TGF-β inhibition induced similar phenotypes in MSCs, in terms of
contractility and matrix synthesis. Through comparative promoter analysis, the decoupled
contractility/synthesis response uncovered NKX2.5 as a mechanosensitive transcription factor
with slow-acting repressive effects on cell tension, particularly on SMA expression. As
discussed in Chapter 2, Lamin-A is known to regulate SRF, while SRF regulates ACTA2;
however, a 60% knockdown of LMNA only led to 40% reduction of ACTA2 (Figure 3.19A).
Furthermore, while retinoic acid treatment greatly reduced lamin A levels (Swift et al., 2013b), it
did not completely abrogate SMA expression on long-term stiff-matrix cultures (Figure 3.19B).
These suggest that the NKX2.5 mechanorepressor pathway is largely independent of the
RA/Lamin-A/SRF signaling axis (Figure 3.19C).
As with activators like SRF (Miralles et al., 2003), YAP/TAZ (Dupont et al., 2011) and RARG
(Swift et al., 2013b), nuclear entry/exit seems to be the last step in converting mechanical
signals to an effective cellular response. Posttranslational modifications should also shed light
into the details of the nucleocytoplasmic shuttling of NKX2.5, with initial correlations shown
here with SUMO-1 (Figure 3.18). In classical signal transduction pathways, kinases (unlike
phosphatases) are evolutionarily optimized to react on short timescales. A striking parallel is
observed here with NKX2.5 (much like a phosphatase) slowly acting on longer timescales than,
say, SRF (much like a kinase) in response to matrix stiffness. These findings may benefit novel
applications of specific compounds that target such factors to optimize stem cell therapy in
fibrotic diseases.
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3.4 Materials and Methods
3.4.1 Transcriptional profiling by DNA microarrays
Total RNA was extracted from cells using Trizol and purified by RNeasy (Qiagen) with on-
column DNase digestion according to manufacturer’s protocol. Adherent cells were gently
scraped in Trizol. Total RNA was amplified and converted to cDNA using WT-Ovation Pico
kit (NuGen). Fragmented and biotin-labeled ST-cDNA was generated using WT-Ovation Exon
Module (NuGen). Samples were tested with Human Gene 1.0 ST DNA microarrays (Affymetrix),
used according to the manufacturer’s instructions. Expression data sets were analyzed by
standard Robust Multi-array Averaging (RMA) methods.
3.4.2 Promoter binding analyses
The Genomatix software suite (www.genomatix.de) curates a library of transcription factor
binding site matrices and DNA sequences of promoter regions such as of ACTA2 (IDs:
GXP_236533, GXP_236534) and COL1A2 (GXP_94473). The MatInspector algorithm
(Cartharius et al., 2005) was used to scan promoter sequences for potential transcription-factor
binding sites based on weighted matrix patterns specific to a transcription factor. Core similarity
and matrix similarity scores that range from 0–1 were calculated (Cartharius et al., 2005), and
reach a value of 1 only if the test sequence matches to the most conserved nucleotide at each
position of the matrix. Transcription factor families, with core and matrix similarity scores ≥
0.80, that differentially bind to ACTA2 and COL1A2 were compiled in Table 3.1.
3.4.3 Isolation of embryonic cardiomyocytes
White Leghorn chicken eggs (Charles River Laboratories) were incubated at 37°C, rotated once
per day, until the desired developmental stage was reached. Embryos were extracted at room
temperature by windowing eggs, removing extraembryonic membranes with forceps and cutting
major blood vessels to the embryonic disc tissue to free the embryo. The embryo was placed
68
in a dish containing PBS and quickly decapitated. For E2–E5 embryos, whole heart tubes
(HTs) were extracted by severing the conotruncus and sino venosus. All tissues were incubated
at 37°C in pre-warmed chick heart media (alpha-MEM supplemented with 10% FBS and 1%
Penicillin/Streptomycin, Gibco, 12571-063) until ready for use.
Cell isolation from heart tissue was performed by dicing it to sub-millimeter pieces and then
digesting them with trypsin/EDTA (Gibco, 25200-072). To digest, we incubated tissue pieces
at 37°C in approximately 1 mL trypsin per HT for 13 min with rotation, then for another 2 min
upright to let large tissue pieces settle before carefully removing supernatant and replacing with
an equal volume of fresh trypsin for a final 15-min shake. We stopped digestion by adding an
equal volume of chick heart media. Cells were plated at concentrations of approximately 2×105
cells/cm3 directly on collagen-1-coated PA gels of varying stiffness.
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Table 3.1. Promoter analysis of transcription factor binding to ACTA2 and COL1A2
A. Promoter sequences for comparative transcription factor binding analysis
Gene (Promoter ID) Gene Position Transcription Start Site Promoter Position
ACTA2
(GXP_236533,
GXP_236534)
Chr10:90694831-
90712530
(-)
Chr10:90712580/-30/-
29/-04
Chr10:90707633-
90708233,
Chr10:90712404-
90713080
COL1A2
(GXP_94473)
Chr7:94023873-94060544
(+)
Chr7:94023873
Chr7:94022989-
94024379
B. Top transcription factor binding sites
Matrix
Family
Transcription Factor Strand
Core
Sim.
Matrix
Sim.
Binding Motif
Binding to ACTA2 promoter
V$SMAD Sma- and Mad-related proteins + 1.00 0.97 tctGTCTgaat
V$CEBP CCAAT/enhancer binding protein beta + 1.00 0.97 tttattagGAAAtgg
V$SRFF Serum response factor - 1.00 0.87 gccctgTATGgttaa
V$NKXH Homeodomain factor Nkx-2.5/Csx + 1.00 1.00 cctcaAGTGgttattt
V$NKX6 NK6 homeobox 1 + 1.00 1.00 tcttTTAAttacccg
V$NKXH Homeodomain protein Nkx-3.2 + 1.00 0.99 gggtaAGTGgcgc
V$NKX1 NK1 homeobox 2, Sax1-like - 1.00 0.91 cgggtAATTaaaag
V$NKXH NK2 homeobox 4, NKX 2 DELTA + 1.00 0.88 attccAGTGgctcttt
V$HOMF Homeobox protein HMX3/Nkx5.1 + 1.00 0.97 gaagcAAGTggga
V$HOXF Homeobox C8 / Hox-3alpha + 1.00 0.99 cttttaATTAcccggt
V$HOXF Hox-1.3, vertebrate homeobox protein + 1.00 0.87 ctgacTAATttaggc
V$HOXC Meis homeobox 1 + 1.00 0.98 aacttGATTtataaa
V$ABDB Homeobox B9 - 1.00 0.96 gacccaTAAAatag
V$OCT1 Octamer-binding factor 1 (OCT1) - 1.00 0.95 agcATGCaaagaa
V$STEM Octamer-binding factor 3/4 (OCT3/4) + 1.00 0.93 ttctttGCATgctacc
V$BRN5 POU class 6 homeobox 1 (POU6F1) - 1.00 0.86 aaatcATTAaggtg
Binding to COL1A2 promoter
V$SMAD Sma- and Mad-related proteins - 1.00 1.00 cttGTCTggat
V$SRFF Serum response factor - 1.00 0.82 ccgacATGGgcag
V$NKXH Homeodomain protein Nkx-3.2 + 1.00 0.91 gtctAAGTgctagac
V$HOMF Homeobox protein HMX3/Nkx5.1 + 1.00 0.93 cctacAAGTggcct
V$HOXF Hox-1.3, vertebrate homeobox protein - 1.00 0.85 aaaTAATaaagccc
V$HOXC Meis homeobox 1 - 1.00 0.88 gtctgGATTtaccag
V$ABDB Homeobox B9 + 1.00 0.89 aactggTAAAtcca
V$OCT1 Octamer-binding factor 1 (OCT1) + 0.75 0.85 gatCTGCaaattct
V$STEM Octamer-binding factor 3/4 (OCT3/4) + 1.00 0.97 gagtctGCATgtcta
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Figure 3.1. Genes relevant to mechanobiology in development. Relative expression
levels of genes relevant to mechanobiology in development, from extracellular matrix proteins
to transcription factors, in embryonic stem cells (ESC), adult fibroblasts, and fibroblast-
derived induced-pluripotent stem cells (iPSC). Dataset is curated from the submission by
Liu et al. (2011a) to the public Gene Expression Omnibus (GEO) repository (GDS3892,
http://www.ncbi.nlm.nih.gov/sites/GDSbrowser). Arrows indicate the interactions of
outside-in signaling components from matrix to nucleus.
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Protein names (Gene) Total Peptides Sti/Soft
Alpha-actinin-1 (ACTN1) 35
Alpha-actinin-4 (ACTN4) 55
Palladin (PALLD) 11
Myosin light chain kinase, smooth muscle (MYLK) 18
Myosin Phosphatase-Targeting Subunit (MYPT1) 25
Collagen alpha-1(I) chain (COL1A1) 16
Collagen alpha-2(I) chain (COL1A2) 20
Collagen alpha-1(VI) chain (COL6A1) 27
Collagen alpha-2(VI) chain (COL6A2) 22
Collagen alpha-3(VI) chain (COL6A3) 9
5.2
2.3
1.1
0.9
0.9
0.9
0.8
1.0
0.9
0.4
A B
STIFF
SOFT
ACTA2 1.88 ± 0.07
CALD1 1.40 ± 0.07
ROCK1 1.23 ± 0.02
ROCK2 1.23 ± 0.02
MYPT1 1.15 ± 0.06
MYLK4 1.07 ± 0.04
MYH9 1.07 ± 0.02
ACTN1 1.05 ± 0.04
ACTN4 1.02 ± 0.01
PALLD 1.04 ± 0.05
NKX2-5 0.98 ± 0.11
SRF 0.94 ± 0.05
YAP1 1.01 ± 0.09
ACTA1 0.97 ± 0.06
COL1A1 0.89 ± 0.02
COL1A2 0.86 ± 0.02
COL6A1 0.76 ± 0.04
COL6A2 0.79 ± 0.02
COL6A3 0.74 ± 0.02
Gene Symbol
Low
High
Figure 3.2. Transcriptomic and proteomic profiles of MSCs on gels. A, Microarray profiling
of contractility- and matrix-relevant mRNA expression levels from MSCs cultured for 1 day on
soft (0.3 kPa) or stiff (40 kPa) collagen-1 coated PA gels. B, Proteomic profiling of 2-day MSC
cultures on PA gels. Cell lysates were run on SDS-PAGE and gel bands in the range of ∼110–
160 kDa were run on the mass spectrometer. Colors of gene/protein symbols indicate gene
abundance, while those of ratios indicate up- or downregulation relative to soft-gel cultures.
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Figure 3.3. Matrix stiffness downregulates collagen-I matrix synthesis in MSCs.
A, Immunofluorescence staining of α-smooth muscle actin (red) and procollagen-1 (green) in
MSCs cultured for 2 days on soft, scar-like (0.3 kPa, with embedded collagen), and stiff gels.
Hoechst 33342 for DNA stain, blue. Scale bar, 50 µm. B, Western blot of procollagen-1 levels
of MSCs cultured for 7 days on gels; HSP70 was used as normalization control.
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Figure 3.4. Stiff gels coated with collagen-2 reduced collagen-1 in MSCs. A, Mesenchymal
stem cells cultured on collagen-2 coated PA gels for 7 days, labeled for collagen-1 (red), F-actin
(green) and DNA (blue). B, Quantification of collagen-1 production on gels showed decrease
with gel stiffness. Scale bar, 50 µm.
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Figure 3.5. TGF-β is sufficient but not necessary for α-smooth muscle actin expression.
A, Immunofluorescence staining of procollagen-1 (green) and α-smooth muscle actin (red)
in mesenchymal stem cells cultured on soft (0.3 kPa), scar-like, and stiff (40 kPa) gel for
2 days (top panel), with TGF-β1 (10 ng/mL) (middle), or with TGF-β receptor inhibitor (10 µM
SB505124, bottom). Hoechst 33342 for DNA, blue. B, Western analysis of the abovementioned
conditions with Hsp-70 as normalization control.
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Figure 3.6. NKX family of transcription factors: promoter binding and gene abundance.
A, Analyses of promoter binding by NKX and Serum Response Factors families using the
MatInspector tool (www.genomatix.de; Cartharius et al., 2005) on ∼1200 base-pairs upstream
of transcription start sites (red arrows) of ACTA2 (also see Table 3.1). B, Relative abundances
within the NKX family transcriptome derived from human MSCs revealed NKX2-5 to be the most
abundant.
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Figure 3.7. Matrix stiffness modulates Nkx2.5 expression in embryonic cardiomyocytes.
A, Immunofluorescence staining of Nkx2.5 (left) and sarcomeric α-actinin (right, red) in
embryonic day-5 (E5) chick cardiomyocytes plated on 6 kPa PA gels for 3 days. Hoechst 33342
for DNA, blue. Scale bar, 50 µm. B, Quantification of i) total Nkx2.5 intensity and ii) nuclear-to-
total Nkx2.5 intensity in E5 chick cardiomyocytes cultured on soft (0.3 kPa) and stiff (40 kPa)
gels for 3 days. ∗p < 0.05.
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MFPSPALTPTPFSVKDILNLEQQQRSLASGDLSARLEATLAP
ASCMLAAFKPEAYSGPEAAASGLAELRAEMGPAPSPPKCSP
AFPAAPTFYPGAYGDPDPAKDPRADKKELCALQKAVELDKA
ETDGAERPRARRRRKPRVLFSQAQVYELERRFKQQRYLSPA
ERDQLASVLKLTSTQVKIWFQNRRYKCKRQRQDQTLELLGP
PPPPARRIAVPVLVRDGKPCLGDPAAYAPAYGVGLNAYGYN
AYPYPSYGGAACSPGYSCAAYPAAPPAAHAPAASANSNFVN
FGVGDLNTVQSPGMPQGNSGVSTLHGIRAW
Figure 3.8. MSCs express NKX2.5 with some modifications. A, Western analysis of NKX2.5
in MSCs revealed multiple band shifts. B, Western analysis of wild-type Nkx2.5 overexpressed
in A549 cells, with the expected molecular weight of 35 kDa, as well as bands that may be post-
translationally modified. C, Mass spectrometry analysis of proteins in the 30–40-kDa range
from Nkx2.5-overexpressing A549s confirmed Nkx2.5-antibody specificity with the detection of
7 peptides unique to Nkx2.5 and their abundance ranking relative to other proteins in that range.
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Figure 3.9. Matrix stiffness modulates NKX2.5 localization in MSCs., Immunofluorescence
staining of NKX2.5 (top) and α-smooth muscle actin (bottom, red) in MSCs on soft (0.3 kPa,
left) and stiff (40 kPa, right) PA gels for 7 days. Scale bar, 50 µm. Insets: Magnified images of
nuclei; scale bars, 20 µm. Hoechst 33342 for DNA, blue.
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Figure 3.10. NKX2.5 is a slow-acting mechanorepressor of α-smooth muscle actin. MSCs
cultured for 1 (left), 2 (middle) or 7 days (right) on soft (0.3 kPa, blue) or stiff (40 kPa, red) gels
differed in their dynamic range of SMA expression. NKX2.5 depletion from the nucleus took
several days and led to ∼8-fold upregulation of SMA in stiff-gel cultures. Inset: Western blot of
NKX2.5 from soft- and stiff-gel cultures. HSP90 as loading control.
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Figure 3.11. Subcellular localization of Nkx2.5 by mutating its nuclear localization signal
(NLS). A, MSCs on rigid substrates leads to nuclear export of NKX2.5, which can interact
with stress fibers or otherwise degrades. B, Amino acid sequence of mouse Nkx2.5 with
highlighted alanine- and proline- (A/P) rich regions (gray) and DNA-binding homeodomain
region (green). The NLS sequence (red) is mutated in NLS1, NLS2 and NLS3 versions of
Nkx2.5 as indicated. C, A549 cells were transfected with wild-type and NLS-mutated Nkx2.5
plasmids and immunolabeled 2 days after transfection with anti-Nkx2.5 antibody (green). Only
NLS3 mutant localized in the cytoplasm. Hoechst 33342 for DNA, blue. Scale bar, 10 µm.
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Figure 3.12. NKX2.5 can reprogram the stiff phenotype of MSCs. A, Overexpression of
wild-type and NLS-mutated Nkx2.5 (green) in MSCs (white arrows) cultured on rigid plastic.
Insets: Magnified nuclei with overexpressed NKX2.5. DNA-edge (white) is superimposed.
Scale bars, 50 µm. B, i) Fold-changes in Nkx2.5 intensity upon overexpression; ii) Nuclear/total
ratio of Nkx2.5 was increased in NLS1 and NLS2, but reduced in NLS3; iii) SMA expression is
abrogated with overexpressed nuclear-localized Nkx2.5 iv) with concomitant reduction of stress
fiber count, v) cell and vi) nuclear areas. Mean ± s.e.m. ∗p < 0.05, ∗∗p < 0.01 when compared
to untreated control.
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Figure 3.13. Extranuclear localization of NKX2.5. A, Immunofluorescence of NKX2.5 (red)
in MSCs showed localization to stress fibers as visualized by α-smooth muscle actin (green).
B, NKX2.5 was found to localize in lamellipodia with myosin phosphatase-1 (MYPT1) in A549
cells. Scale bars, 10 µm.
83
A NKX2.5
SMA
DNA
0.0
1.0
2.0
0 5 20 30
Blebbistatin Treatment Time (h)
 
NKX2.5
Nuclear/Total
NKX2.5
Nuclear
SMA
** **
**
*
B
NKX2-5 1.0 1.2
EGR1 2.4 1.4
MYPT1 1.1 0.8
ACTA2 0.4 0.5
MEF2C 1.3 1.4
GATA4 1.0 1.1
NPPA 0.9 1.0
GJA5 0.9 1.1
CALR 0.8 1.0
ECE1 0.9 1.1
ADORA1 1.0 1.0
ACTC1 1.0 0.1
MYOCD 1.0 0.1
LMNA 0.8 0.9
SRF 0.8 0.6
MYH9 0.7 0.7
YAP1 1.1 0.9
ANKRD1 0.3 0.1
HSP90AB1 1.0 1.0
TCP Bleb
TCP Ctrl
11 kPa Bleb
11 kPa Ctrl
NKX2.5
Repressor
Pathway
NKX2.5
Cardiac
Pathway
SRF
YAP
House-
keeping Low High
Figure 3.14. Blebbistatin rescues NKX2.5 depletion from the nucleus in stiff-gel cultures.
A, Kinetics of NKX2.5 expression and localization in MSCs cultured on rigid plastic and treated
with blebbistatin for 4—27 h revealed loss of SMA (red) and nuclear enrichment of NKX2.5
(gray). Hoechst 33342 for DNA, blue. Scale bar, 50 µm. Mean ± s.e.m. ∗p < 0.05,
∗∗p < 0.01 when compared to untreated control. B, Transcriptomic profiling of MSCs treated
with blebbistatin on 11 kPa gels or rigid plastic (TCP) for 24 h revealed decreased SRF and
SRF-target levels (e.g. ACTA2). Downstream targets of NKX2.5 related to cardiac specification
were downregulated and/or lowly-expressed.
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Figure 3.15. NKX2.5 decreases with long-term stiff-substrate cultures of MSCs. A, Long-
term culture (high passage, >P5) of MSCs on tissue culture plastic leads to decreased levels
of NKX2.5, while SMA levels are maintained. β-tubulin as loading control. B, Quantitation of
Western blot. Mean ± s.e.m. ∗p < 0.05, compared to low-passage MSCs.
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Figure 3.16. TGF-β inhibition recapitulates matrix stiffness-induced nuclear exit of
NKX2.5. A, Inhibition of TGF-β pathway (1-day treatment with SB505124, 10 µM; 7-day culture)
depleted NKX2.5 (top) from nuclei of MSCs cultured on both soft (0.3 kPa, left) and stiff (40 kPa,
right) gels, and increased SMA (bottom). Hoechst 33342 for DNA, blue. Scale bar, 50 µm. B
Scatterplots of SMA intensity vs nuclear/total NKX2.5 in MSCs on soft vs stiff matrices with or
without TGF-β inhibition (1-day treatment, 7-day culture). C, Sustained treatment (3 days) of
SB505124 reduced NKX2.5 but increased SMA levels in MSCs.
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Figure 3.17. Crosstalk of NKX2.5 and Serum Response Factor (SRF) with TGF-β
signaling. A, At basal TGF-β and SRF activity, soft matrix-induced nuclear localization of
NKX2.5 represses ACTA2, while stiff matrix induces high SRF activity (Swift et al., 2013b)
that could then inhibit TGF-β induction of collagen-1 (Lee et al., 2007). B, Inhibiting TGF-β
(i.e. with SB505124 treatment) prevents collagen-1 but not SMA, due to basal SRF activity on
soft matrix, or to enhanced SRF activity and nuclear exit of NKX2.5 on stiff matrix. Sustained
TGF-β inhibition also reduces total NKX2.5 expression leading to further SMA expression.
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Figure 3.18. Post-translational modifications of NKX2.5. A, NKX2.5 was also found in
the Golgi apparatus, as visualized by fluorescein-labeled wheat germ agglutinin (WGA; right,
green). In contrast, procollagen-I staining (left, green) is predominantly in the endoplasmic
reticulum. DNA, blue. Scale bar, 10 µm. B, Colocalization of NKX2.5 and SUMO-1 in
MSC nuclei. (Top) MSCs with small spread areas had nuclear NKX2.5 (left) and enhanced
nuclear SUMO-1 intensities (middle), but not in highly spread MSCs with NKX2.5-depleted
nuclei (bottom). Hoechst 33342 staining for DNA (right). Scale bar, 50 µm.
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Figure 3.19. NKX2.5 de-repression on stiff matrix, which couples SMA and Lamin-A
upregulation, is independent of retinoic acid/Lamin-A/SRF axis. A, Effect of LMNA
knockdown to ACTA2 levels in MSCs. B, Quantitative immunofluorescence of lamin A and
α-smooth muscle actin (SMA) levels in MSCs cultured on gels with or without Retinoic Acid
(RA, 1 µM) treatment for 7 days (mean ± s.e.m.). C, Retinoic acid (RA) disrupts stress-
stabilized lamin-A assembly (but only partially disrupts downstream SMA) through retinoic acid
receptor-γ (RARG) (Swift et al., 2013b), as NKX2.5 functions independently as a slow-acting,
mechanosensitive repressor of SMA.
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Chapter 4
Systems Mechanobiology:
Tension-inhibited protein turnover
is sufficient to physically control
gene circuits
Portions of this work appear in Science 341:1240104, 2013 and Current Biology 24:R1-R7,
2014.
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Abstract
Mechanotransduction pathways convert forces that stress and strain structures within cells into
gene expression levels that impact development, homeostasis, and disease. The levels of
some key structural proteins in the nucleus, cytoskeleton, or extracellular matrix have been
recently reported to scale with tissue- and cell-level forces or mechanical properties, and so the
mathematics of mechanotransduction becomes important to understand. Here, we show that if
a given structural protein positively regulates its own gene expression, then stresses need only
inhibit degradation of that protein in order to achieve stable, mechanosensitive gene expression.
This basic ‘use it or lose it’ module is illustrated by application to meshworks of nuclear lamin
A, mini-filaments of myosin II, and extracellular matrix collagen fibers – all of which possess
filamentous coiled-coil/supercoiled structures. Past experiments not only suggest that tension
suppresses protein degradation mediated and/or initiated by an enzyme, but also that transcript
levels vary with protein levels as key transcription factors are regulated indirectly by these
structural proteins. Coupling between modules occurs within single cells and between cells
in tissue, as illustrated during embryonic heart development where cardiac fibroblasts make
collagen that cardiomyocytes contract. With few additional assumptions, the basic module has
sufficient physics to control key structural genes in both development and disease.
4.1 Introduction
Polymer physics provides fundamental explanations for how elasticity and viscosity of diverse
polymer systems often scale as power laws with polymer concentration (Rouse, 1953), even
when the polymers interact or assemble (Doi and Edwards, 1978). Living organisms are of
course built from biopolymers (Figure 4.1A), and assembling proteins such as extracellular
matrix (ECM) collagens, which are the most abundant proteins in metazoans, exhibit gel
elasticities that indeed scale with concentration when purified and reconstituted (Yang et al.,
2009). Not surprisingly perhaps, tissue stiffness not only scales with collagen levels, but is
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actually dictated by the amount of collagen with soft tissues such as brain having much less
collagen than stiffer tissues such as muscle (Swift et al., 2013b). However, biopolymers that
include many other key structural proteins within cells and tissues are subject to a variety of
enzymatic processes of degradation and synthesis on time scales that can be only hours or
days (Schwanhausser et al., 2011; Eden et al., 2011). How the mechanics of a tissue or cell
reaches or maintains a steady state is therefore a fundamental question of biopolymer physics
that impacts the form, function, and dysfunction of cells and tissues in general.
Some of the earliest examples of tension-mediated protein stability were demonstrated
in cyclically beating neonatal rat heart cells, where components of the contractile myofibril
assembly such as cardiac actin (Sharp et al., 1993) and myosin heavy chain (Byron et al.,
1996) were found degraded when contractile activity was reduced. For collagen, recent
evidence suggests mechanical strain stabilizes against enzymatic degradation (Flynn et al.,
2010). High matrix stiffness is further associated with an increased stress or tension in the cell
(Discher et al., 2005), and the key contractile protein, myosin II, responds to matrix stiffness by
assembling into stress fibers and increasing in amount (Rehfeldt et al., 2012; Engler et al.,
2006). More recently, we have shown that nucleoskeletal lamin-A level scales with tissue
microelasticity E, with higher lamin A levels giving physically stiffer nuclei in stiffer tissues (Swift
et al., 2013b). Lamin A and myosin II thus seem to mechanically couple to the collagenous
matrix (Figure 4.1A) in ways that are prescribed by polymer physics. These coiled-coil proteins
that assemble into structural networks are prime candidates as biological tension sensors,
transducing similar mechanical signals from the ECM to the nucleus (Wang et al., 2009).
Genome-wide measurements of the production and degradation dynamics of mRNA as
well as protein in mouse fibroblasts (NIH 3T3) in standard cultures (Schwanhausser et al.,
2011) have shown that mRNA and protein half-lives are fairly uniform within structural
groupings of collagens, integrins, and actomyosin components (Figure 4.1B). Collagen and
actomyosin modules differ significantly in half-lives, and the integrins exhibit intermediate
half-lives consistent perhaps with these membrane proteins serving as intermediary linkages
between ECM and the cytoskeleton. Even structural proteins on the nuclear envelope such as
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lamins exhibit largely coordinated expression as a single module, with half-lives similar to those
for the actomyosin module. This seems consistent with mechanically coordinated responses
of the nuclear lamina to cytoskeletal stresses (Houben et al., 2007). Regardless, for a given
structural gene (S) and its corresponding protein (s) in a module, the typical rate equations are:
dS
dt
= α− β (4.1)
ds
dt
= γ − δ (4.2)
where α and γ are synthesis rates, and β and δ are degradation rates for mRNA and protein,
respectively. Any of these terms could in principle be functions of S, s and other factors such as
tension. The goal here is to identify a possible minimal model that fits the current understanding
of tension coupling to gene expression.
Tension on coiled-coil assemblies has been shown to suppress the affinity of a
phosphorylating kinase/protease that initiates enzymatic solubilization/degradation (Flynn et al.,
2010; Raab et al., 2012; Swift et al., 2013b; Buxboim et al., 2014). Like pulling on a wet
rope to wring out water, tension squeezes out free volume or sterically shields a binding site
via coiled-coil assembly to prevent enzyme access. Single-molecule studies of collagen have
suggested tension-enhanced degradation (Adhikari et al., 2011), but such short polymers tend
to unwind under tension, whereas rope-like polymers would tend to tighten their coils and
knots. Regardless of the mechanism, the rate of degradation can be generally represented
by Michaelis-Menten kinetics (Michaelis and Menten, 1913) as
δ(s) = δ0s
n
Kns + sn
(4.3)
where δ0 is the maximum degradation rate at saturating concentrations of substrate s, such as
a coiled-coil protein assembly. Ks is an enzyme affinity for the substrate and is also a surrogate
for tension; n is a cooperativity coefficient ≥ 2 that is typical of multimeric interactions. By
incorporating Equation (4.3) to Equation (4.2) and by including an experimentally supported
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mechanism for transcriptional control, we solve the system of differential equations at steady
state and arrive at a relationship between S, s and tension-surrogate Ks.
Starting with the model above applied to lamin A, we then extend the model to two structural
modules that couple the nucleoskeleton to the cytoskeleton. Dynamics on the tissue-level is
then illustrated with a ‘two-cell type’ model of embryonic heart development. Our parsimonious
models thus likely elaborate systems-level behavior of structural modules that respond to
mechanical stress. These results have implications for both the physiology and pathophysiology
of diseases involving structural proteins, from early cardiac development to stress-dependent
aging.
4.2 Results and Discussion
4.2.1 Tension-inhibited degradation of coiled-coil proteins
With lamin-A as a representative mechanosensitive protein, we predicted systems-level trends
by constructing a parsimonious model of its gene circuit that takes into account transcription
(α) to be regulated by its own protein and protein turnover (δ) to be tension-dependent
(Figure 4.2A). For simplicity, synthesis of messenger RNA (mRNA) and protein as well as
degradation of mRNA were all assumed to be linear with rate constants of order unity (to
eliminate bias on one biological process). Other variations for the reaction orders of α, β,
and γ in Equations (4.2) and (4.3) were explored further in Appendix B, and only first-order
rates can sufficiently recapitulate experimental observations. Kinetic measurements of lamin-
A changes with mechanical perturbations are clearly needed to further develop the model.
Nonetheless, Lamin-A protein is known to feed back on its own message as it positively
regulates it own transcription factor, retinoic acid receptor-γ (RARG) (Swift et al., 2013b), such
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that the respective rate equations for lamin-A mRNA (L) and protein (l) are:
dL
dt
= α˜ · l − β˜ · L (4.4)
dl
dt
= γ˜ · L− δ(l) (4.5)
where α˜ is a first-order protein-induced mRNA-production rate constant, β˜ is a first-order
mRNA-degradation rate constant, γ˜ is a first-order mRNA-translational rate constant, and δ
is a tension-dependent protein-degradation rate, as described in Equation (4.1).
Time evolution of protein (l) and mRNA (L) can be analytically solved with example
trajectories in Figure 4.2B as a phase plot of l(t) versus L(t) converging to {lss, Lss}. The
phase plot suggests a stable steady-state node, lending both mathematical consistency and
biophysical relevance to the parsimonious model. It also suggests that the initial protein and
mRNA levels dictate expression dynamics. For example, for lamin A and the nucleoskeletal
module, which have stable protein levels but unstable mRNA levels (Schwanhausser et al.,
2011), protein dynamics for a given tension set point (K) are predictably well-controlled and
stabilize linearly towards steady-state (Figure 4.2B, upper left quadrant). Lamin A is of course
known for tethering heterochromatin near the nuclear envelope, and thus, may need a relatively
stable protein expression. Other gene groups with unstable mRNAs include RNA-binding
proteins (Schwanhausser et al., 2011). On the other hand, the ECM module has the opposite
trend (Figure 4.1B); the kinetics of the model predicts that for highly stable mRNA but short-lived
protein levels, the dynamics are nonlinear (Figure 4.2B, lower right quadrant). That is, protein
levels would overshoot prior to stabilizing at a steady-state level. The kinetics of this regime
was verified by tracking collagen protein expression in mesenchymal stem cells over time from
suspension to attachment, starting at low collagen protein levels but with COL1 mRNA levels
remaining relatively stable among structural genes (Figure 4.1B). With an initially high mRNA
level (Figure 4.2B, lower right quadrant), collagen protein tended to overshoot prior to stabilizing
at a lower steady-state concentration, as was observed experimentally over 7 days (Figure 4.3).
Other gene groups in this regime include those involved in defense response and homeostasis
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(Schwanhausser et al., 2011).
Ultimately, tension dictates lamin-A (and LMNA) levels regardless of initial conditions, such
that at steady state,
dl
dt
= 0, dL
dt
= 0 (4.6)
Equations (4.4) and (4.5) can be analytically solved for n = 2 to yield nonzero steady-state
values for l and L,
{lss, Lss} =
12
(
β˜δ0
γ˜α˜
)
− 12
√√√√( β˜δ0
γ˜α˜
)2
− 4Kl, α˜lss
β˜
 (4.7)
Based on the steady-state analysis above, a solution only exists if
(
β˜δ0
γ˜α˜
)2
− 4Kl > 0 (4.8)
Although steady-state values depend on the various rate constants, we assumed all to be
important and of order ∼1 as we focus on Kl: at high stresses where lamin-A assembly is
favored, Kl increases so that phosphorylation-mediated lamin-A degradation (Buxboim et al.,
2014) decreases. Plotting steady-state lamin-A levels lss against different values for Kl fit
a power-law lss ∼ K2l (for n = 2). As a test of whether such a model could capture
key experimental trends, computational results showed that if Kl = (Tension)0.3, then lss ∼
(Tension)0.7 (Figure 4.2C), which parallels the scaling of lamin A with tissue microelasticity E
(noting that Tension∼ E; Swift et al., 2013b). The set of equations and trends delineated above
also applies obviously to collagen as it defines tissue E itself, and it was found to scale more
strongly experimentally (E1.5; Swift et al., 2013b).
4.2.2 Mechanical coupling of coiled-coil modules in series
We further developed our model by coupling two coiled-coil modules, e.g. cytoskeleton and
nucleoskeleton, with nonmuscle myosin (e.g. MYH9) and lamin A as representatives in their
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respective modules. Lamin-A {L, l} and nonmuscle-myosin {M,m} message and protein
circuitry is schematically presented in Figure 4.4A. In particular, expression kinetics were
described as coupled rate equations for the respective transcripts {L,M} and proteins {l,m}:
dL
dt
= α˜1 · l − β˜1 · L (4.9)
dl
dt
= γ˜1 · L− δ1 · l
nl
Knll + lnl︸ ︷︷ ︸
coupled to myosin
(4.10)
dM
dt
= α˜2 ·m− β˜2 ·M (4.11)
dm
dt
= γ˜2 ·M − δ2 · m
nm
Knmm +mnm︸ ︷︷ ︸
coupled to matrix E
(4.12)
Again for simplicity, mRNA degradation and translation rates were assumed of first order.
Lamin-A protein positively regulates one of its transcription factors (RARG; Swift et al., 2013b)
as does MYH9 with one of its transcription factors (SRF ; Miralles et al., 2003) so that each
enhances its own transcription (with rate constants, α˜1 and α˜2, respectively). Mechanical
regulation of protein phosphorylation and turnover has been demonstrated in recent studies
(Raab et al., 2012; Swift et al., 2013b; Buxboim et al., 2014), and so we described lamin-A
and myosin turnover with suitable Hill functions (rate constants δ1, δ2). Specifically, lamin-A
turnover is dictated by Kl = mx/nl for some x that dictates sensitivity of lamin-A degradation
to myosin-generated stress. Myosin protein turnover depends on matrix elasticity as simply
Km = Ey/nm for some y that represents the affinity for myosin degradation. Both Km
and Kl effectively couple matrix mechanics to cytoskeletal stress, which in turn tenses the
nucleoskeleton (Figure 4.1A; Wang et al., 2009).
Equations (4.9) to (4.12) above were solved numerically at steady state (all derivatives = 0;
see Appendix B.3). Rate constants and free parameters were adjusted collectively within an
order of magnitude of each other (Appendix B.1.2) to reflect the observed similar half-lives of
the modules (Figure 4.1B). In the simplest case, we first assumed synthesis and degradation
rate constants to be equal (α˜1 = α˜2; β˜1 = β˜2; γ˜1 = γ˜2;nm = nl;x = y) and observed
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that, for any given E, the range of expression for myosin is larger than that for lamin A
(Figure 4.4B). This likely reflects the matrix-cytoskeleton-nucleoskeleton assembly in series
(Figure 4.1A). Nonetheless, as matrix and cell tension suppresses protein phosphorylation
and turnover, steady-state levels monotonically increase with matrix E, consistent with coupled
mechanoregulation of lamin A and myosin (Buxboim et al., 2014), just as with SMA and lamin A
(Figure 2.12A).
If we consider a first-order effect of lamin-A protein on MYH9 transcription via SRF pathway
(Swift et al., 2013b), then we can modify Equation (4.11) as:
dM
dt
= α˜2 ·m+ α˜3 · l − β˜2 ·M (4.13)
In this case, numerical analysis showed that the dynamic range of myosin increased further due
to matrixE and lamin-A contributions, but not the relative slope of the myosin–lamin-A response
to matrix E (Figure 4.4C). The relative sensitivity of each module is instead dependent on
x and y. If sensitivity of lamin A to degradation (x) is increased (or decreased), then more
(lesser) myosin protein is required to generate the same stress that maintains the original
lamin-A protein level (Figure 4.5A). Reducing x is similar to decoupling nucleoskeletal and
cytoskeletal modules, as was done experimentally by ectopic expression of SUN2, a nuclear
membrane protein that connects the nucleoskeleton to the cytoskeleton, which led to reduced
lamin-A levels (Swift et al., 2013b). On the other hand, if sensitivity of myosin to degradation (y)
is increased, then at low E the steady-state levels of myosin (and indirectly, lamin A) is much
lower; at sufficiently high matrix E, myosin (and lamin) levels remain relatively unperturbed
(Figure 4.5B). Experiments that observed this prediction include phosphomimetic mutants of
nonmuscle myosin IIA that enrich myosin in the soluble pool, and nonphosphorylatable mutants
that promote myosin-rich stress fibers (Raab et al., 2012).
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4.2.3 Logistic coupling between collagen and myosin in cardiac
development
Systems biology can potentially build an integrated understanding of the electrophysiological
and physical processes involved in cardiac physiology and pathophysiology. It might also help
identify therapeutic targets. Understanding how the balance between mechanical stiffness and
contractile ability of the myocardium is achieved with age and pathological changes ultimately
requires a systems-level model to guide hypotheses. The expression of actomyosin contractility
proteins and collagen, among hundreds of abundant proteins, parallel myocardial stiffening in
development (Majkut et al., 2013). Both static/cyclic and uniaxial/biaxial strains encourage
collagen matrix deposition by cardiac fibroblasts (MacKenna et al., 2000), as passive and
active contraction increase throughout cardiac development. However, as contractility (or
myosin levels) increasingly strains the developing heart tissue, we postulate that fibroblast
proliferation is ultimately limited by the stiffness of their environment, which correlates strongly
with collagen-1 levels (Majkut et al., 2013; Swift et al., 2013b). The various components of
the developing heart matrix and cytoskeleton, and any other functionally relevant signaling
proteins must be integrated into a realistic physical model of the observed mechanics.
Thus, we considered using our simplified model that focuses on the mechanical interaction
between the collagenous matrix deposited by cardiac fibroblasts and the contractile activity of
cardiomyocytes.
To explore possible general mechanisms, a coupled network of myosin {M,m} and
collagen {C, c} mRNAs and proteins can be modeled within the developing myocardium
(Figure 4.6A). With collagen produced primarily by cardiac fibroblasts, the rate of collagen
mRNA production is assumed to be proportional to the fibroblast population, which is in turn
limited by tissue stiffness imparted by collagen matrix density, such that:
dC
dt
= α˜1 · c
nf−1
k
nf
f + cnf︸ ︷︷ ︸
fibroblast crowding
−β˜1 · C (4.14)
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The collagen mRNA production rate of fibroblasts increases at low collagen matrix densities up
to a critical collagen concentration (and hence matrix stiffness), then it decreases thereafter; the
amplitude and critical point of this biphasic behavior are modulated by nf and kf , respectively
(Figure 4.6B).
The concept of tension-mediated degradation is again applied here for collagen protein.
Collagen matrices have been shown to be stabilized (against degradation) by applied tension
(Flynn et al., 2010), such that:
dc
dt
= γ˜1 · C − δ˜1 · c
nc
Kncc + cnc︸ ︷︷ ︸
coupled to myosin
(4.15)
Cardiomyocytes are of course the primary contributors of myosin-mediated tension in cardiac
tissue, such that Kc = mx/nc for some x that dictates the extent of myosin-mediated
collagen degradation. Additionally, myosin-II molecules under tension remain assembled and
abundant (Majkut et al., 2013; Swift et al., 2013b), with some evidence of tension-suppressed
phosphorylation of nonmuscle myosin-II suggesting an intermediate step (Raab et al., 2012).
Striated muscle myosin-II is certainly turned-over in vivo (Ball et al., 1987), and its disuse
probably favors degradation and muscle atrophy. Thus, the transcript (M ) and protein (m)
rate equations for myosin are coupled to collagen such that:
dM
dt
= α2 ·m− β2 ·M (4.16)
dm
dt
= γ2 ·M − δ2 · m
nm
Knmm +mnm︸ ︷︷ ︸
coupled to collagen
(4.17)
where Km = cy/nm , for some y.
With rate constants and free parameters adjusted within an order of magnitude of each other
Appendix B.1.3, Equations (4.14) to (4.17) were solved numerically Appendix B.4 and obtained
best agreement with the reported experimental results. By representing the basic assumptions
on fibroblast population crowding (Equation 4.14) and tension-stabilized proteins (Eqs. 4.15
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and 4.17), the model was able to recapitulate the logistic growth kinetics (Figure 4.6C) observed
experimentally for myosin and collagen protein levels in a developing heart (Majkut et al., 2013).
The model also predicted, perhaps not surprisingly, that mRNA levels should exhibit the same
trends as the protein counterparts (Figure 4.6C).
4.3 Conclusion
The detailed molecular mechanism for tension-mediated stabilization of rope-like coiled-coil
polymers is not yet known, but tension in polymer fibers and a polymer network is thought to
sterically or conformationally prevent protease binding to collagen fibers (Flynn et al., 2010) or
kinase binding to myosin minifilaments (Raab et al., 2012) and lamin-A meshwork (Swift et al.,
2013b). Regardless of mechanism, turnover of key structural proteins appears to be mechano-
regulated.
In the models presented here, membrane-bound integrins were implicitly overlooked.
Overexpressing integrin receptors does not change the ability of a cell to spread, as observed
experimentally (Engler et al., 2004b). On the other hand, perturbations to the Linker of
Nucleoskeleton and Cytoskeleton (LINC) complex are understandably more complicated with
observed cellular genotypic effects as it influences chromatin architecture. Nonetheless,
the LINC complex is implicitly included in the x coefficient, as it couples cytoskeletal and
nucleoskeletal responses. Indeed by applying force to nesprin-1, an isolated nucleus with an
intact nuclear lamina stiffens (Guilluy et al., 2014).
To date, most experimental techniques in developmental biology come short of
characterizing a systems-level landscape. Our modeling analysis of collagen and myosin
levels in cardiac tissue development (Figure 4.6) demonstrates that coupled structural modules
are sufficient to recapitulate the dynamics of tissue-level architecture. Given the highly
interconnected signaling pathways in mammalian biology, our work distills the essential
mechanobiological circuits that govern not just intracellular but also tissue-level observations.
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The inherent difficulty of detailing these circuits with accurate rate constants and functional
forms will be addressed by developing more sophisticated “-omic” approaches.
4.4 Methods
The sets of ordinary differential equations (ODEs) that describe the various mechanobiological
systems modeled here are explicitly written in Appendix B. The analytical results were
also derived where applicable. Numerical integration of systems of ODE were performed in
Mathematica (version 8, Wolfram Research). The values of the various rate constants, initial
conditions, etc. used in each model are also included in Appendix B.
Steady-state measurements were obtained by allowing the system to run until the levels of
each species stabilize.
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Figure 4.1. Systems-level view of structural molecules involved in mechanotransduction.
A, A living cell and its microenvironment are built from biopolymers that provide structure; these
molecules assemble and are interconnected to resist stress that arises from development or
disease. B, Protein (top) and mRNA (bottom) half-lives of collagens (teal) membrane-bound
integrins (brown), actomyosin (orange), and nuclear envelope components (red) measured in
NIH3T3 mouse fibroblasts (Schwanhausser et al., 2011). Half-lives are fairly constant within
structural groups suggesting similar dynamics within groups.
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Figure 4.2. Feedback-based mechanobiological gene circuit model for lamin A exhibits
polymer-physics scaling if cell tension suppresses protein turnover. A, Nucleoskeletal
Lamin A protein regulates its own message (LMNA) and assembles in response to tension
from matrix elasticity (Ematrix), which inhibits protein degradation. B, Trajectories of lamin-
A message and protein as the model converges from a range of initial conditions to a
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respectively.
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high (E = 0.4) tension. C, With the known feedback of lamin A on myosin transcription (α3 >
0), both myosin and lamin levels are increased.
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Figure 4.5. Sensitivity analysis of coupled structural modules. A, By varying x, we can
perturb the (slope) sensitivity of lamin A to degradation in response to myosin-generated stress.
B, Varying y perturbs the degradation sensitivity of myosin, but not its coupling with lamin A.
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Figure 4.6. Cardiomyocytes and fibroblasts balance contraction and matrix production
during heart development. A, Assumptions in matrix stiffness limiting fibroblast population α1
(and hence, collagen expression), while encouraging myofibril organization in cardiomyocytes
(and hence, myosin expression) are incorporated in a model where tension derived from each
module inhibits degradation of the other. B, Fibroblast crowding is modeled by a Hill function
(Equation 4.14) with nf and kf as the critical point and amplitude, respectively, of the collagen
message production in response to collagen protein (and hence tension). C, Experimentally
measured changes in both collagen-1 (COL1, teal) and cardiac myosin-II (red) expression
(circles) in a developing embryonic chick heart (Majkut et al., 2013) can be recapitulated by
the model (protein, lines; mRNA, dashed lines).
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Chapter 5
Future challenges in characterization
and mechanochemical control of
stem cell fate
Portions of this work appear in Current Opinion of Biotechnology 28:46-50, 2014 as the cover
article.
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Abstract
Recent experiments have revealed that stem cells respond to biophysical cues as well as
numerous biochemical factors. Nanoscale properties at the cell-matrix interface that appear to
affect adherent stem cells range from matrix elasticity to porosity-dependent matrix tethering
and geometry of adhesive linkages. Some stem cells can also remodel their immediate
environment to influence phenotype, but this depends also on matrix-material properties such
as covalent bonding and soft versus hard materials. Efforts to combine both matrix instructions
and active cell feedback are required to properly direct stem cell behavior.
5.1 Introduction
Within the last ten years, stem cell approaches have become conceivable or even realized
for each of the roughly 200 differentiated cell types in humans. Since most tissue cells are
anchorage dependent – meaning that adhesion to a solid is necessary for cell survival – it is only
sensible that the mechanochemical nature of the support can influence stem cell fate (Discher
et al., 2009). Substrate stiffness, geometry, porosity, and topography are now understood
to influence stem cells, perhaps as much as biochemical factors. Molecular pathways of
cellular mechanotransduction that ultimately affect both cell phenotype and genotype are
slowly becoming clear. Matrix stiffness-dependent lineage commitment of stem cells has been
suggested to involve YAP/TAZ, which are transcription factors previously known to influence
proliferation; newer evidence suggests they are also nuclear mechano-transducers regulated
by Rho GTPase and cytoskeletal tension independent of the canonical Hippo pathway (Dupont
et al., 2011). More recently, mass spectrometry-based scaling between tissue stiffness and the
nuclear envelope structural protein, lamin A, has been reported to co-regulate YAP and SRF,
among other transcription factors, suggesting that increased matrix rigidity leads to nuclear
stiffening as a homeostatic response in all tissue types, including stem cells (Swift et al.,
2013b; Pajerowski, 2007). In Chapter 3, a novel mechano-repressor NKX2.5 was identified via
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bioinformatics analysis and was found to maintain long-term maintenance of stem-cell response
to matrix stiffness . More pathways are likely to emerge as the field gains control over systems-
level technologies and precision design of micro/nano-environments for stem-cell culture in vitro
and in vivo.
Virtually every organ in the body contains resident stem cells or progenitors that contribute
to organ homeostasis or repair. Exploiting stem cells for regeneration of damaged tissue has
spurred research into their multipotentiality as well as immunocompatibility. Therapeutics is
limited in part by in vitro cell expansion as well as materials issues that include the design
of biocompatible scaffolds for co-transplantation. Since many stem cells are anchorage
dependent, injection in vivo should work best if the cells adhere quickly and adequately, but
it is clear in many trials with mesenchymal stem cells (MSCs) that the vast majority of injected
cells die rather than contribute to tissue (Berry et al., 2006). Recapitulating the various stem
cell niches ex vivo is extremely challenging as it involves spatiotemporal regulation of biostimuli
that extend to extracellular matrix architecture (Chapter 1). Nonetheless, understanding the
niche in vitro might help in translation to in vivo (Stevens and George, 2005). In a diseased
setting, engrafted stem cells encounter an inflammatory (early-stage) or fibrotic (late-stage)
environment; a minimal scar-like model described in Chapter 2 recapitulated the heterogeneity
and stiffness of fibrotic tissues, and how different cell types respond to it.
Recent advances as well as challenges in the material control of stem cell multipotency and
lineage commitment are described in this Chapter. By “stem cell”, we refer to cited studies on
MSCs (mesenchymal), NSCs (neural), ESCs (embryonic), iPSC (induced pluripotent), etc., but
we emphasize the generality merely with “stem cell” as mechanochemical rules seem to apply
for all types (see Chapter 1). We attempt to highlight in more detail how the field is beginning
to formulate materials design rules for stem cell cultures down to the nanoscale in terms of
fabrication and/or physical characterization. Approaches are crudely split into soft materials
such as hydrogels that are as soft as most tissues or else hard materials in which the softest
thing in culture is the cell. Remarkably, there seem to be ways – i.e. rules — to manipulate
‘boundary conditions’ in order to fool cells into responding to a hard material in a manner similar
111
to that on a much softer material, and vice versa.
5.2 Soft matter control
Tissue stiffness or elasticity is dictated by the extracellular matrix (ECM). Even a few minutes
of incubation with collagenase can soften a tissue dramatically (Majkut et al., 2013). ECM
is comprised of a network of fibrous proteins, such as collagens, that are crosslinked in a
homophilic or heterophilic manner. A hierarchical polymeric network of variable density allows
for a broad range of characteristic microelasticities for tissues: brain (Georges et al., 2006) and
fat (Patel et al., 2005) are hundreds of Pascals in stiffness whereas cartilage (Guilak et al.,
2005) and pre-calcified bone (Engler et al., 2006) are dozens of kiloPascals or even stiffer on
larger length scales. Precise regulation of physical properties of the ECM seems to match and
couple to the applied mechanical forces that contribute to specific cell differentiation programs
in adult tissue and likely in the embryo. A differential cell response to both ECM elasticity
and dimensionality (i.e. 2D vs 3D) – termed ECM mechanosensing — has been observed
in vitro through various materials approaches, particularly with natural (Rehfeldt et al., 2012)
and synthetic (Engler et al., 2006) hydrogels. Naturally derived polymers such as silk (Wang
et al., 2006), collagen and hyaluronic acid matrices (Nicodemus and Bryant, 2008) are currently
used as delivery vehicles for cell transplantation. Synthetic scaffolds are chosen based on
properties that range from biostability or biocompatibility to biodegradability and porosity. Inert
synthetic hydrogels are used in vitro for studying cell behavior such as migration, proliferation,
and differentiation. Indeed, due to the chemistry that can sometimes be very simple, physical
parameters such as elastic and viscous moduli can be precisely tuned to mimic biological
tissues.
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5.2.1 Synthesis, Functionalization and Characterization
The basic components for polymer hydrogel synthesis are a monomer, a crosslinker, and an
initiator of polymerization. The ratio and concentration of monomer and crosslinker are varied
to achieve desired viscoelastic properties, perhaps to mimic a normal or diseased tissue or
perhaps to be distinct from a tissue. For example, a myocardial infarct stiffens two- to three-
fold more than a normal heart tissue (∼20kPa; Berry et al., 2006). Rheological methods
provide measures of a material’s complex modulus or stiffness (G∗) composed of both an
elastic modulus (G′) and a viscous modulus (G′′). These can be measured as a function
of frequency of oscillatory shear with a rheometer, and one typically considers that the 1-Hz
beating of the heart is close to the high frequency limit of biological relevance. Solid tissues
are mostly elastic, with G′ values ranging from 0.1–100 kPa (Engler et al., 2006). Material-
dependent cell responses are thus strongly influenced by the elastic component of a hydrogel,
at least when G′′ is two orders of magnitude lower than G′. Viscous matrix effects on cell
morphology are nonetheless interesting based on recent examples in the literature (Murrell
et al., 2011; Cameron et al., 2011).
Control of hydrogel chemistry can extend to spatiotemporal control of polymerization (Kloxin
et al., 2009) and micropatterning (Marklein and Burdick, 2010). Non-uniform substrates might,
for example, mimic a heterogeneous cell microenvironment, but in such a case, rheological
measurements must be done at the cellular scale. One particularly attractive method is
atomic force microscopy (AFM): a cantilever probe reflects a laser onto a photodiode detector
that measures small variations in cantilever deflection as it indents a substrate. For such
heterogeneous substrates, an AFM cantilever can probe and create a viscoelastic map along
a preset path. For example, we examined “durotaxis” in Chapter 2, which is a phenomenon in
which a cell migrates toward increasing matrix stiffness (Lo et al., 2004), and so we and others
made hydrogels with stiffness gradients and used AFM to measure the steepness of those
gradients (Raab et al., 2012; Isenberg et al., 2009).
Most hydrogels require some form of functionalization to promote favorable cell-material
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interactions. This can be done by linking cell-adhesive moieties into the polymer backbone,
via functional side group chemistry. The well-known integrin-binding tripeptide RGD can
be incorporated into a methacrylated polymer backbone (e.g. methacrylated polyethylene
glycol) via a Michael-type addition reaction between thiol (from a cysteine moiety in the cell-
adhesive peptide) and methacrylate groups (Marklein and Burdick, 2010). Large matrix proteins
like fibronectin and collagen can also be covalently crosslinked into an amide-containing
hydrogel backbone via a heterobifunctional crosslinker that contains a primary amine-reactive
succinimidyl ester and a photoactivatable nucleophilic azide (e.g. Sulfo-SANPAH) (Pelham and
Wang, 1997). Conventional matrix functionalization of hydrogel systems involves copious
coverage of the cell-material interface with cell-adhesive molecules, to ensure that cell
attachment is not adhesion ligand-limited and that any differential cellular response is due to
physical properties of the matrix.
5.2.2 Advances in Soft Matter Research
Whereas past studies of the cell-material interface have focused on the effects of relatively
homogeneous and weakly varying materials on stem cells, recent efforts have begun to
address some aspects of matrix micro-/nano-heterogeneity. Tools that allow non-invasive
in situ measurements of cell-material interaction at the small scales could ultimately clarify
governing principles for cell-material interface design. Fabrication approaches are equally
important as they should allow for systematic nanoscale control of substrate topography and
functionalization. A great deal of effort is spent in (1) understanding how matrix ligand is
presented at the interface, (2) how a cell adheres and applies ligand- and stiffness-dependent
traction forces to a material, and (3) how a cell remodels or secretes adhesion-relevant
molecules or other factors presented at its interface.
Insight into the first two issues above has been obtained from integrin clustering that occurs
when a cell exerts traction forces in response to stiff matrix. Huebsch et al. (2010) found that
increasing matrix resistance to adhesion ligand displacement leads to a greater ability of a cell
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to exert traction forces that allow for more stable integrin-ligand bonds (Kong et al., 2005) and
ultimately, greater propensity toward osteogenic commitment. They encapsulated stem cells in
3D non-degradable, RGD-modified alginate gels for which elastic modulus (2.5–110 kPa) was
varied by the extent of ionic crosslinking. In contrast to 2D studies where cells spread more
in response to increased matrix rigidity, encapsulation in 3D nanoporous hydrogels maintained
a rounded shape. The ability of encapsulated cells to rearrange integrin-RGD linkages in the
ionically crosslinked alginates is estimated by fluorescence resonance energy transfer (FRET)
of rhodamine- and fluorescein-labelled RGD peptides clustering near the cell membrane (Kong
et al., 2005) and appeared to depend on matrix stiffness and seemed optimal at an intermediate
stiffness (∼20–30 kPa), where integrin receptors were estimated to probe 50 nm into the
surrounding environment. In contrast, Khetan et al. (2013) made 3D, covalently crosslinked,
methacrylated hyaluronic acid (MeHA) hydrogels (G′ = 4–95kPa) and found a lack of matrix
elasticity dependence, with most cells driven toward adipogenic commitment. Differences
between the two systems start with the nature of crosslinking and could extend to how growth
factors in serum differentially bind the gels or permeate gel pores; differentiation-relevant factors
in serum include TGF-β, which is in a large latent complex that must immobilize near a cell in
order for traction forces to release the active growth factor (Buscemi et al., 2011). Determination
of traction-dependent stiffness sensing involves assumptions about matrix stiffness at the cell
interface and is difficult to assess when cells are embedded in 3D. Yet stiffness sensing seems
essential for osteogenic commitment and appears dysregulated in cells entrapped within overly
restrictive microenvironments. Moreover, dynamically fluctuating tractions in and around focal
adhesions are necessary for matrix rigidity sensing (Plotnikov et al., 2012).
The third issue mentioned above is how stem cells release their own matrix and other
factors or else modify pre-existing factors. Minimizing cell- or serum-derived matrix deposition
has been investigated to some extent on ultra-low fouling substrates that are zwitterionic in
nature (Jiang and Cao, 2010). In all such studies, proteomic scale analysis of substrates is
increasingly needed to define cell and serum responses to manufactured microenvironments;
using antibodies to assess whether serum fibronectin or vitronectin adsorbs or not is just a start.
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Once measurements are made, however, efforts to prevent adsorption of proteins either from
cells or serum can also point the way toward preventing foreign body reactions if materials are
to be taken in vivo (Zhang et al., 2013). In a study of 3D PEG hydrogels tethered with small-
molecule functional groups, stem cell fate had been found to be directed toward adipogenic or
osteogenic differentiation with respective functionalization of the gels by t-butyl or phosphate
(Benoit et al., 2008). The effects of such small functional moieties have been speculated to
reflect differences in cell-derived, lineage-specific matrix molecules which accumulate at the
cell-matrix interface and ultimately direct differentiation. In the RGD-modified MeHA hydrogels
cited above (Khetan et al., 2013), local matrix changes due to cell-derived matrix did not seem to
impede RGD-integrin signaling, but no measurements of matrix were pursued — obviously, 3D
microenvironments require deeper and more careful characterization than 2D, at least because
of the complexity of protein entrapment through the depth of a gel. When the ability of a cell
to probe its surrounding matrix is constrained by complexities of adsorption or encapsulation
within covalently crosslinked gels, matrix rigidity (or other physical property) effects on stem cell
fate might also be limited.
It must be noted that while promoting cell attachment with matrix-immobilized RGD peptides
ensures direct matrix sensing, there are subtle, yet still confounding differences with tethering
actual matrix proteins. For example, fibronectin contains an RGD motif, among other motifs,
that seems to activate other signaling pathways within the cell, and at least affect cell migration
differently from the minimal sequence (Maheshwari et al., 2000). Matrix tethering is an issue
raised recently by Trappmann et al. (2012). In contrast to utilizing RGD peptides, which do not
involve the tethering issues in 3D, collagen fibrils were functionalized on 2D polyacrylamide (PA)
gels or polydimethylsiloxane (PDMS) elastomers. While stem cells differentiated as expected
on soft versus stiff PA gels, the apparent stiffness of PDMS had no effect. Unfortunately, soft
PDMS is well-known to be difficult to make and requires careful nanoscale characterization;
it is often accompanied by increased viscosity (or even fluid-solid heterogeneity), which was
not characterized but could adversely affect stem cell differentiation (Cameron et al., 2011) as
well as epithelial cell sheet motion (Murrell et al., 2011). Additional studies by Trappmann
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et al. (2012) involved decreasing the collagen anchoring points on stiff gels by lowering
sulfo-SANPAH crosslinker concentration with the effect of inducing a soft gel phenotype that
prevented epidermal stem cell differentiation. Ligand density is likely decreased as sulfo-
SANPAH is lowered (see Figure 2.4C), and cells simply do not spread on stiff PA gels when
adhesive ligand is limiting (Engler et al., 2004a). Nonetheless, the idea of decoupling material
stiffness and cell-matrix interactions may have application, as was attempted in our ‘scar in a
dish’ model (see Chapter 2).
5.3 Hard matter approaches
The ligands, assembly, and overall architecture of ECM can all influence cell behavior.
Parsing some aspects of cell-matrix interaction at the molecular level might be addressed with
precision nano-fabrication of hard materials as used in the semiconductor industry. An array of
nanotechnology-driven in vitro cell culture platforms has been reviewed recently (Kshitiz et al.,
2011), and so we highlight here a couple of key advances in nanotopography design principles
that are inspired from ECM (Kim et al., 2010) and/or inspire precise control of ECM (Dalby et al.,
2007b; Kilian and Mrksich, 2012) in directing cell fate. Nanoscale patterning of cell adhesion
ligands is problematic with soft materials because many cell types generate sufficient traction
strain to rearrange any ligand pattern.
A minimal adhesive matrix unit required for cell attachment, spreading and migration is an
important research question that is addressed with nanopatterned RGD surfaces. Schvartzman
et al. (2011) varied RGD ligand spacing, density and cluster size, and found that a spacing
of 60 nm in a cluster with a minimum of 4 RGD ligands is sufficient to support cell spreading.
Although ligand surface density might have a role, they speculated that talin, an integrin-binding
scaffolding protein that has 4 potential binding sites, is involved in the integrin clustering-derived
cell response. Focal adhesion formation was indeed enhanced for a ligand spacing of ∼50 nm,
concomitant with increased cell attachment, migration (Maheshwari et al., 2000) and stiffening
(Selhuber-Unkel et al., 2010). In the alginate gel studies by Huebsch et al. (2010), the highest
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RGD density is roughly ∼1 RGD ligand per 70×70 nm2 surface patch on an entrapped stem
cell of 10-µm radius. This might explain why matrix rigidity-dependent traction forces enhance
clustering. In addition, highly ordered 120 nm ligand pits spaced 300 nm apart in a square
lattice have been shown for ‘best’ maintaining adult stem cell multipotency for several weeks,
whereas the exquisite sensitivity of stem cells to a pit placement offset of <50 nm leads to
differentiation (Dalby et al., 2007b; McMurray et al., 2011). Integrin clustering is thus likely to
be a key to some pathways that signal intracellular changes from cytoskeleton to nucleus (Swift
et al., 2013b; Dalby et al., 2007a). Epigenetic state and cell reprogramming can also be affected
by nanopatterns in recent studies by Downing et al. (2013), which indicate how much more we
need to learn about the cell-matrix interface.
5.4 Conclusion
In the heterogeneous microenvironments referred to as stem cell niches, various mechanical
and biomolecular cues are integrated to maintain pluripotency or induce differentiation.
Biological applications of both soft and hard matter systems to elucidate cell-material
interactions have certainly increased our understanding of the stem cell-matrix interface, but
there is much more to learn. Soft matter substrates are more tissue-mimetic than hard
substrates, but precise nanoscale control of the cell-matrix interface provides powerful tools
for understanding and directing a wide range of cell behaviors. Cell-derived molecules are
generally overlooked when designing and using many of these materials, whether hard or soft,
and 2D or 3D, although some stem cell types express lesser matrix than others. Controlling
endogenous expression of such factors by methods such as siRNA knockdown is one approach.
Ultimately, new design rules that are emerging for material control of stem cell fate could help
with in vitro cultures as well as implantable scaffolds for more stem cell-based therapies.
118
Appendix A
Supplementary Information for
Chapter 2
A.1 Adhesion and Thin-film Corrections for
scar-like0.3kPa gel
In order to create 2D hydrogel substrates for cell culture, polyacrylamide (PA) gels were
sandwiched between an allysilanated bottom coverslip and a nonreactive top coverslip (18-
and 25-mm in diameter, respectively; Fisher). Embedding fibrous collagen in polyacrylamide
hydrogels exhibited tackiness to the gel surface post-polymerization. That is, removal of the top
coverslip required more force than without the fibers. This again provided evidence for interfacial
localization of the fibers. To correct for tackiness of scar-like0.3kPa gel, the force required
to remove the top coverslip was measured with a custom-made and calibrated polystyrene
cantilever (spring constant, ksp = 804.6 N/m), attached at one end to a syringe pump (RS-232,
Harvard Apparatus) and the other to a nylon string, which in turn was firmly attached to the
top coverslip of a stage-immobilized gel. Syringe pump was set to ‘pump mode’ pulling the
cantilever-string-coverslip setup at an effective velocity of 0.4 mm/s. The removal process was
observed with a side-view camera to determine when the pulling string should be stopped and
maintained at constant force (zero velocity). Maximal deflection of the cantilever (translated
to maximal force of the pulling string) was observed just before coverslip was fully detached
(or just before cantilever relaxes back to zero deflection) and used to calculate gel adhesion
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force. Adhesion force on scar-like0.3kPa gels was found to be 84 ± 20% higher than on pristine
0.3-kPa gels (n = 5).
The effective elasticity can be derived from rigid cylinder (i.e. coverslip of length a) pulling
from a soft elastic thin film by assuming non-uniform Boussinesq-type stress distribution at the
interface. The force per unit length F /a (along x) or P that propagates from the edge of the
coverslip can be derived as (Chung and Chaudhury, 2005):
P = D∂
3uz
∂x3
(A.1)
where uz is displacement field in the z-direction, D is bending stiffness of the coverslip. Since
coverslip bending is coupled to the deformation of the hydrogel below it, the characteristic stress
decay length, ε, from the edge of contact is (Ghatak et al., 2004):
ε ∼
(
Dh31
E1
)1/6
(A.2)
where h1 and E1 is the height and Young’s modulus of the thin film, respectively. By taking
uz ∼ δ2, where δ2 is the thin film extension length at the applied pull-off force, F , and x ∼ ε, we
can analyze equation (A.1) with (A.2) at the scaling level:
P ∼ F
a
∼ Dδ2
ε3
∼ D
1/2E
1/2
1 δ2
h
3/2
1
(A.3)
or simply (by removing material-property constants),
E1 ∼
(
F
δ2
)2
(A.4)
for which we can estimate elasticity increase with addition of embedded collagen. Assuming
adhesion work is constant (related to surface tension and interfacial area), δ2 is thus inversely
correlated to E1, which can be derived to scale as δ2 ∼ E−1/31 (Chung and Chaudhury, 2005).
From equation (A.4), this leads simply to
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E1 ∼ F 6 (A.5)
Thus, surface elasticity of scar-like0.3kPa gels, with a first approximation due to tackiness, is
Escar−like0.3kPa ∼ E0.3kPa(1.84± 0.2)6 ∼ 5.8− 22 kPa (A.6)
AFM measurements of scar-like0.3kPa gel in Figure 2.4ii was corrected based on this adhesion
considerations.
A fluorescence microscopy-based elasticity approximation can also be used to correct for the
observed thin film (Figure 2.2B) of embedded collagen fibers near the gel interface. For
pure collagen gels, storage modulus G′ (Pa) is a function of temperature and concentration,
c (mg/mL). At 37°C, this was found to scale as (Yang et al., 2009)
G′ ≈ 22 c2.1 (A.7)
From confocal stack reconstruction, we found embedded collagen localization within 10
microns near the surface of scar-like0.3kPa PA gel of ∼80-micron thickness (Figure 2.2B). Since
the embedded fibers are putatively stiffer than the compliant PA around them, Equation (A.7)
was assumed to still apply at least in the regions near fiber bundles. For scar-like0.3kPa
gels, surface coverage is ∼30% based on Sirius red and/or collagen immunofluorescence
staining, which matches that of mdx and DMD skeletal muscle tissue cross-sections (∼20–30%;
Turgeman et al., 2008; Mann et al., 2011). This leads to a corrected collagen concentration
from the nominal value of 0.4 mg/mL to an effective c = 11.6 mg/mL. Plugging this value into
Equation (A.7), and assuming Young’s modulus (E) = 2.9G′, we predicted an effective EC fiber
stiffness of Eeff ∼ 11 kPa.
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A.2 Theoretical analysis of lateral pulling curves
For an elastic substrate medium bounded on one side by a plane (e.g. PA gel on coverslip)
with a point force F on applied on its free surface, the distribution of displacement, u, along the
surface (z = 0) has been determined in equilibrium by Landau and Lifshitz (1986) as:
ux =
1 + σ
E
· 1
r
{
−(1− 2σ)x
r
Fz + 2(1− σ)Fx + 2σx
r2
(xFx + yFy)
}
(A.8)
where E is Young’s modulus of the medium, σ is Poisson’s ratio, and r =
√
x2 + y2. A similar
formula for uy was also found. We assumed that the lateral pulling force was applied to a
small region and that the measured displacement profiles were obtained at large distances
away from the initial loading point to satisfy Equation (A.8). In the simplest case (of a
Boussinesq approximation) where x = r, (y = 0), displacement far enough from the loading
point scales as ur = aB/r, for some Boussinesq constant, aB . Since such scaling leads to
infinite displacement at x = r = 0, we also fit exponential scaling (ur = a0e−br, for some
characteristic decay constant b; Figure 2.5ii) to set the approximate maximum displacement at
the initial loading point, a0. Both scalings agree well (R2 > 0.9), as evidenced by the fitted
scaling constants in Figure 2.5B.
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Appendix B
Supplementary Information for
Chapter 4
B.1 Mechanobiological gene circuits:
systems of ordinary differential equations
We consider tension-mediated stabilization of polymeric, structural proteins as the basis for
systems mechanobiology – as explored here mathematically for single, coupled and population-
coupled modules. To incorporate the stabilizing effect of tension (Ks) on protein (s) we define
degradation term δ as a Hill function as in Equation (4.3) in the main text:
δ(s) = δ0s
n
Kns + sn
Structural proteins of the extracellular matrix, cytoskeleton, or nucleoskeleton are
understandably polymeric, but in an effort to parsimoniously define a mechanobiological gene
circuit, tension-mediated turnover is assumed to depend simply on total protein level, as one
might assume for proteasomal degradation of monomeric proteins. This also assumes that
polymerization and depolymerization rates are relatively rapid compared to the rates defined
here.
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B.1.1 Single-module gene circuits: reaction-order stability
A single module refers to a particular gene and its corresponding protein and is described
by general rate equations that define what factors affects synthesis and turnover. The set of
ordinary differential equations (ODEs) for a single module is simply:
dS
dt
= α− β
ds
dt
= γ − δ
S and s represent the gene and protein, respectively, whose synthesis (α, γ) and degradation
(β, δ) rates describe their expression levels. Ultimately, the value of Kl (and hence, E) dictates
the steady state values, regardless of the initial condition; while the functional forms of the
various rates dictate the stability and dynamics of the system. For the given Hill-functional form
of δ above, we explored the various reaction-order forms of the other rates that converge to a
steady state solution. As discussed in the following sections, none of the other functional forms
properly recapitulate the matrix elasticity-dependence of structural proteins unless the protein
degradation rate is tension-dependent, and protein positively regulates its own gene expression.
Rate-order forms by Schwanhausser et al.
Schwanhausser et al. (2011) quantified proteomic and transcriptomic half-lives under the
following rate equations:
dS
dt
= α˜− β˜ · S
ds
dt
= γ˜ · S − δ˜ · s
where α˜, β˜, γ˜, δ˜ are rate constants. A phase plot below of protein (s) and mRNA (S),
while varying relative protein synthesis/degradation rates (γ˜/δ˜) and the relative mRNA
synthesis/degradation rates (α˜/β˜), shows that mRNA-relevant rates scale mRNA and protein
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levels (blue line), but protein-relevant parameters do not (red line). This was expected from
α/β
s(t)
S(t)
α = 1
β = 2
γ = 3
δ = 4
~
~
~
~
~ ~
~ ~γ/δ
attractor loci
the chosen forms of the rate equations above as the protein kinetics does not affect its mRNA.
Thus, in the search for the appropriate forms of the rate equations that capture the variations in
structural protein expression with matrix elasticity, E, the ones described by Schwanhausser et
al. are not sufficient.
Zeroth-order α, tension-dependent δ
Now if we consider changing degradation rate to be tension-dependent, keeping others similar
to above:
dS
dt
= α˜− β˜ · S
ds
dt
= γ˜ · S − δ0s
n
Kns + sn
In this case, we get the following phase plot where varying Ks, and hence protein levels, does
not affect mRNA levels. This is again not physically relevant as we expect that both mRNA and
protein levels should respond to Ks (or E).
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First-order rates, tension-dependent δ
First-order rates were chosen for the main text as they recapitulate experimental observations
for the mechanobiological gene circuit of lamin A (Swift et al., 2013b).
dS
dt
= α˜ · s− β˜ · S
ds
dt
= γ˜ · S − δ0s
n
Kns + sn
With the lack of precise values for rate constants published in literature, we chose O(1) values
for the parameters. For the purposes of display in Figure 4.2 of the main text, we used the
following values for each of the rate constants:
Parameter Value
α˜ 1
β˜ 2
γ˜ 3
δ0 4
n 2
Protein and mRNA levels were initialized in the range {0, 1}, as shown in the phase plot in
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Figure 4.2.
Unstable steady states: higher-order rates
The following higher-order (p ≥ 2) cases have divergent steady states, and hence not
biologically relevant:
• α = α˜ · sp; β = β˜ · S; γ = γ˜ · S;
• α = α˜ · s; β = β˜ · S γ = γ˜ · Sp;
• α = α˜ · sp; β = β˜ · Sp γ = γ˜ · Sp;
B.1.2 Two-Module Gene Circuit
Assuming first-order rates (except for protein degradation rates), the set of ODEs for coupled
two-module gene circuit is:
dL
dt
= α˜1 · l − β˜1 · L
dl
dt
= γ˜1 · L− δ1 · l
nl
Knll + lnl
dM
dt
= α˜2 ·m (+α˜3 · l)− β˜2 ·M
dm
dt
= γ˜2 ·M − δ2 · m
nm
Knmm +mnm
where Ks = f(s) and Ks = f(tension), for some functional form (e.g. power-law). For lamin-
myosin coupling, we chose Kl = mx/nl and Km = Ey/nm .
The following values for rate constants were used in the simulations presented in
Figure 4.4B, C of the main text:
Parameter Value
{α˜1, α˜2} {1.1, 1.1}
{β˜1, β˜2} {5, 5}
{γ˜1, γ˜2} {1.2, 1.2}
{δ1, δ2} {5, 5}
{nl, nm} {2, 2}
{x, y} {0.44, 0.44}
127
with E = 0.003 − 0.4, to represent the order of magnitude range elasticities in cell-on-
gels experiments (0.3–40 kPa; Swift et al., 2013b). The different molecular species were all
initialized as L(0) = l(0) = m(0) = M(0) = 0.005.
B.1.3 Two-Module, Tissue-level Mechanobiological Gene Circuit
The set of ODEs for population-level coupling of two modules (e.g. collagen and myosin levels
in a developing heart) are:
dC
dt
= α˜1 · c
nf−1
k
nf
f + cnf
− β˜1 · C
dc
dt
= γ˜1 · C − δ˜1 · c
nc
Kncc + cnc
dM
dt
= α2 ·m− β2 ·M
dm
dt
= γ2 ·M − δ2 · m
nm
Knmm +mnm
where Kc = mx/nc for some x, Km = cy/nm , for some y.
The following values for rate constants were used in the simulations in Figure 4.6 (unless
otherwise specified):
Parameter Value
{α˜1, α˜2} {5.2, 4.1}
{β˜1, β˜2} {5, 3}
{γ˜1, γ˜2} {3, 1.5}
{δ1, δ2} {6.5, 7}
{nf , nc, nm} {2, 1.6, 3.7}
{x, y, a0} {0.51, 0.39, 0.89}
The different molecular species were initialized with the following values:
Species Initial Value
C 0.00051
c 0.00051
M 0.011
m 0.011
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B.2 Analytical Solution for Single-Module Gene Circuit
For the case that δ is tension-dependent and all other rates are first-order (B.1.1), as in the main
text, such that at steady state we have:
dS
dt
= 0 = α˜ · s− β˜ · S (B.1)
ds
dt
= 0 = γ˜ · S − δ0s
n
Kns + sn
(B.2)
For the simplest case of n = 2 and substituting Eq. (B.2) to Eq. (B.1), we get (after removing
null solution):
s3 − β˜δ0
γ˜α˜
s2 + γ˜K2s = 0 (B.3)
s2 − β˜δ0
γ˜α˜
s+ γ˜K2 = 0 (B.4)
Equation (B.4) is simply a quadratic equation, which has two solutions:
s1,2 =
1
2
(
β˜δ0
γ˜α˜
)
± 12
√√√√( β˜δ0
γ˜α˜
)2
− 4Kl (B.5)
Stability analysis shows that the larger solution is an unstable node, such that we only have one
biologically relevant, non-zero steady state:
{sss, Sss} =
12
(
β˜δ0
γ˜α˜
)
− 12
√√√√( β˜δ0
γ˜α˜
)2
− 4Ks, α˜sss
β˜
 (B.6)
where the rate constants must have values that obey the following:
(
β˜δ0
γ˜α˜
)2
− 4Ks > 0 (B.7)
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B.3 Numerical Solution for Two-Module Gene Circuit
For the coupled mechanobiological gene circuit (in ??), we employed a numerical solver
(Mathematica; version 8, Wolfram Research) to conduct kinetic and steady-state analyses. The
outputs for the code below are found in Figure 4.4B (plot of E = 0.4 kinetics, and steady-state
plot). To obtain Figure 4.4C plots, we changed the value of J (in code; equivalent to α˜3 in ??)
from 0 to 1.8. To obtain plots for the case of E = 0.003 , we changed the upper limit of the For
loop to i < 0.0031.
1 test = Partition[
2 Flatten[Reap[
3 For[i = .003, i < .4, i = i + .05, Clear[a, b, h, g, s , L, l , m, M, J, j , t , x, y, A1, A2
, E1, q, r ];
4 a = 1.10; b = 5; g = 1.20; h = 5; x = .440; y = .44; J = 0; j = 1.1; q = 5; r = 1.20;
s = 5; A1 = 2.0; A2 = 2.0; E1 = i; Ko = 9.2;
5 s = NDSolve[{l’[t] == a∗L[t] − b∗l[t],
6 L’[ t ] == g∗l[t] − h∗L[t]^A1/(M[t]^x + L[t]^A1),
7 m’[t] == J∗L[t] + j∗M[t] − q∗m[t],
8 M’[t] == r∗m[t] − s∗M[t]^A2/(E1^y + M[t]^A2),
9 l [0] == .005, L[0] == .005, m[0] == .005, M[0] == .005}, {l, L, m, M}, {t, 0, 1000}];
10 Plot[Evaluate[{l[t], L[t ], m[t], M[t]} /. s ], {t, 0, 1000}, PlotRange −> {{0, 15},
{0.00001, 1.1}}, PlotStyle −> Thick] Sow[{L[1000] /. s, l[1000] /. s, M[1000] /. s,
m[1000] /. s }]];][[2, 1]]], 4]; Lss = test [[All, 1]]; lss = test [[All, 2]]; Mss =
test[[All, 3]]; mss = test[[All, 4]];
11 Plot[Evaluate[{200 L[t], 200 M[t]} /. s ], {t, 0, 100},P lotRange −> {{0, 25}, {0., 10}},
PlotStyle −> Thick, PlotLegends −> {"Lamin␣protein", "Myosin␣protein"}]
12 ListLogLogPlot[{Partition[Riﬄe[200 Lss, 200 Mss], 2]}, PlotRange −> {{0.5, 20}, {0.5,
20}}]
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B.4 Numerical Solution for Tissue-level Coupled Gene
Circuit
The code listed below refers to ?? on modeling of the mechano-regulated dynamics of collagen
production (by cardiac fibroblasts) and myosin expression and hence contraction levels (by
cardiomyocytes), which prints out Figure 4.6C:
1 Clear[a, b, h, g, u, s , F, f , M, m, J, j , t , T, x, y, k0]
2 a = 5.2; b = 5; g = 3; h = 6.5; x = .51; j = 4.1; q = 3; r = 1.5; s = 7;
3 A1 = 1.6; A2 = 3.7; y = .39; z = 2; k0 = .89;
4 s = NDSolve[{F’[t] == a∗f[t]^(z − 1)/(k0^z + f[t]^z) − b∗F[t],
5 f ’[ t ] == g∗F[t] − h∗f[t]^A1/(m[t]^x + f[t]^A1),
6 M’[t] == j∗m[t] − q∗M[t],
7 m’[t] == r∗M[t] − u∗m[t]^A2/(f[t]^y + m[t]^A2),
8 F[0] == .00051, f[0] == 0.00051, M[0] == 0.011, m[0] == 0.011},
9 {F, f , M, m}, {t, 0, 1000}];
10 LogPlot[Evaluate[{100 F[t], 100 f[t ], 100 M[t], 100 m[t]} /. s ], {t, 0.5, 1000},
11 PlotRange −> {{0, 15}, {0.1, 100.}}]
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Appendix C
Standard biological laboratory
protocols and reagents used
C.1 Cell culture
Cell cultures were kept in 5% CO2 humidified incubators and maintained at 37 °C. Cells were
passaged at 70–80% confluence using 0.05% trypsin-EDTA solution and fed every 2–3 days
for cell lines (e.g. A549 cells) or 3–4 days for primary cell cultures.
Human mesenchymal stem cells (MSCs), isolated from human donor bone marrows
(anonymous donors with Institutional Review Board approvals), were obtained from Stem
Cell and Xenograft Core, University of Pennsylvania School of Medicine, and cultured
using standard methods (Pittenger et al., 1999). Cells were expanded on tissue culture
flasks (Corning, Inc.) in low-glucose (1 g/L) Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and 100 µg/ml penicillin and 100 µM
streptomycin (P/S) and used at passages 3–5 for all cell-on-gel cultures. All reagents were
purchased from Gibco (Life Technologies) unless otherwise specified.
C.2 Quantitative Immunofluorescence Microscopy
For immunofluorescence staining, cells were fixed with 3.7% formaldehyde (Sigma) in PBS
for 15 min at RT and washed with PBS twice for 5 min. Blocking was done for 1 hr
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with 1% BSA in PBS. All primary antibodies (see Table C.6 for specifications) in PBS with
0.025% Tween-20 (PBST) were incubated at RT for 1 hour or overnight at 4 °C. All donkey
secondary antibodies (at 1:1000 dilution, Alexa series from Invitrogen) were used to stain
primary antibody-labeled fixed cells for 1 hour at RT in PBST. Actin filament (F-actin) staining
was done in PBS with 100 ng/ml TRITC-phalloidin (Sigma) for 20 min at RT. Hoechst 33342
(Invitrogen) was used at a concentration of 1 µg/ml in PBS to stain for DNA for 5 min at RT.
Quantitative immunofluorescence of immunolabeled proteins of interest and their localization
was performed using an inverted microscope (IX-71, Olympus) with a 20× LCACh objective
(NA 0.40) and a Cascade CCD camera (Photometrics). Image acquisition was performed
under Image-Pro Plus software (Media Cybernetics, Inc.) and image analysis was done using
ImageJ software. For quantitative immunofluorescence microscopy, samples were imaged
under the same specifications of exposure times and gains. If two different exposure times were
necessary for quantification between samples, both exposure times were performed for those
samples to ensure that images were in the linear range of fluorescence intensities with respect
to exposure times. Control samples incubated only with secondary antibody (no primary-
antibody incubation) were also imaged as negative control under the same specifications and
used as background-intensity subtraction during image processing.
C.3 Cell Morphometrics
Intensity analyses and cell-morphology quantification were performed in ImageJ software.
From images acquired from immunofluorescent samples, F-actin and myosin IIB rear/front
polarization ratios were determined by splitting the cell into two equal areas (rear and front)
and plotting the fluorescence vs length. For nuclear-localized stains (e.g. of NKX2.5), a
dedicated channel for Hoechst 33342-stained nuclear DNA was used to delineate nuclear
versus cytoplasmic/whole-cell regions. The ratio is the total integrated fluorescence of the
rear half over the front half of the cell. Cell area and aspect ratio were quantified from
myosin IIA or F-actin immunofluorescence (since they consistently stain the whole cell body).
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Before comparing different sample conditions, integrated intensity of a particular protein was
normalized to background value (secondary antibody-only control).
C.4 Transfection protocol
For transfecting plasmid DNA and siRNA into cell cultures, Lipofectamine 2000 Reagent was
used according to Invitrogen’s instructions. After 4–24 h post-transfection, culture media was
freshly replaced. Western analysis of transfection efficiency was performed on cell lysates 48 h
post-transfection.
C.5 Western Blotting and Analysis
Adherent cells such as MSCs, THP1-derived macrophages, and A549 cells were trypsinized,
then pelleted and washed in cold PBS twice prior to addition of RIPA lysis buffer (1.0 vol% NP40,
2 mM EDTA, 150 mM NaCl, 50 mM Tris-HCL, 0.1 wt% SDS, 0.5 wt% sodium deoxycholate)
at 4 °C for 30 minutes. During incubation, the pellet solution was sonicated to fully break
down cell particulates. The pellet solution is then centrifuged at 12,000 rpm at 4 °C for
20 min and the collected supernatant lysate can be stored at –80 °C or immediately used.
LDS (4×, Thermo Scientific) / β-mercaptoethanol solution at 11:1 v/v is then added at 36%
of lysate volume and boiled at 90 °C for 10 min prior to gel electrophoresis. Boiled lysates
were cooled at RT, loaded onto 3–8% NuPAGE Novex Tris-Acetate gels (Life Technologies);
after gel-run, the gel-immobilized protein bands were transferred to blotting paper (iBlot PVDF,
Life Technologies) using an iBlot gel transfer device (Life Technologies) set at P3 for 7 min.
Blots were blocked with 5% non-fat milk (American Bioanalytical) in TBST for 1 hour at RT
and then desired primary antibodies in TBS were added overnight at 4 °C. HRP-conjugated
secondary antibodies (ECL™, GE Healthcare) in TBST with 5% milk were added for 1 hour
at RT. Two 10-min TBST washes were performed in between above steps, and a final TBS
wash before precipitate development. Chromosensor (GenScript), a chromogenic substrate,
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was finally added to generate a precipitate for the ECL reaction that should appear visible
within 5–10 min.
C.6 Statistical Analyses
An independent samples t-test was used when there were only two different sample means.
One-way ANOVA was used for matrix elasticity effects on cell morphometrics, protein
expression, etc. Two-way Analysis of Variance (ANOVA) with Tukey post-hoc test was used
for time-lapse cell migration experiments with time-dependent displacement values between
conditions. Statistical significance was determined at α = 0.05 level. All statistics analyses
were done in Microsoft Excel.
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Table C.1. Polyacrylamide gel precursor formulations#
Nominal
Elasticity
(kPa)
Volume (µL) of
40% Acrylamide
stock
Volume (µL) of 1.5%
w/v Bis-Acrylamide
stock
Volume (µL) of
distilled water
0.3 75 47 874.84
3.0 112 70 812.86
10 150 93 750.68
20 200 93 696.00
40 250 200 539.47
#1 µL of N,N,N’,N’-Tetramethylethylenediamine (Sigma) and 10 µL of 10% w/v Ammonium Persulfate
(Sigma) was added to a ∼1 mL gel formulation to initiate polymerization.
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Table C.2. Primary antibody specifications#
Antigen
Host species and
Reactivity
Clone, Catalog
number, Vendor
Concentration/Dilution
and Application
β-Actin
mouse
anti-β-Actin IgG1
C4, sc-47778, Santa
Cruz Biotechnology
1 µg/mL (Western blot)
β-tubulin goat anti-β-tubulin ab21057, Abcam 1 µg/mL (Western blot)
Collagen-1
mouse
anti-collagen
type I IgG11
COL-1, C2456, Sigma
1:1000 (Indirect
immunofluorescence – IF)
Myosin IIB
(MIIB)
rabbit anti-MIIB
3404, Cell Signaling
Technology
1:1000 (Western blot),
1:200 (IF)
Myosin IIA
(MIIA)
rabbit anti-MIIA M8064, Sigma 1:200 (IF)
Myosin
phosphatase-1
(MYPT1)
rabbit anti-MYPT1 ab24670, Abcam
1:10000 (Western blot),
1:2000 (IF)
NKX2.5 rabbit anti-NKX2.5
H-114, sc-14033,
Santa Cruz
Biotechnology
1 µg/mL (Western blot, IF)
Lamin A,C
mouse anti-lamin
A,C IgG2b
636, sc-7292, Santa
Cruz Biotechnology
1 µg/mL (Western blot, IF)
Lamin B goat anti-lamin B1
sc-6217, Santa Cruz
Biotechnology
1 µg/mL (Western blot, IF)
Heat shock
protein 90
(HSP90)
mouse
anti-HSP90
AC88, ab13492,
Abcam
1 µg/mL (Western blot)
Heat shock
protein 70
(HSP70)
mouse
anti-HSP70
C92F3A-5, ab47455,
Abcam
1 µg/mL (Western blot)
Pro-collagen
type I
mouse
anti-pro-collagen
type I IgG1
M-38, Developmental
Studies Hybridoma
Bank (DSHB)
1 µg/mL (Western blot, IF)
Sarcomeric
α-actinin
mouse
anti-sarcomeric
α-actinin IgG1
EA-53, MA1-22863,
Sigma
1 µg/mL (IF)
α-Smooth
Muscle Actin
(SMA)
mouse anti-SMA
IgG2a
1A4, A2547, Sigma 1:1000 (Western blot, IF)
SUMO-1
mouse
anti-SUMO-1 IgG1
21c7, DSHB 1 µg/mL (Western blot, IF)
#reactive to human antigen, unless otherwise specified; 1used to stain rat collagen-1, also reactive to
human.
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